Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Bipolar Disorder: HELP
Roger S. McIntyre
Based on 157 articles published since 2010
(Why 157 articles?)
||||
Expertise Level
The expertise of Roger S. McIntyre ranks in the
  • Top 0.0077%
  • ... of 39,139 published authors worldwide on Bipolar Disorder
  • ... from 2010 through 2020
  • ... based on contributions to 157 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases McIntyre, Roger   ·   McIntyre, Roger S
Work Locations
Details
Most likely:    University Health Network of Toronto      
2020
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China; Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China; Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, China; Laboratory of Neuropsychology and Laboratory of Social Cognitive Affective Neuroscience, Department of Psychology, University of Hong Kong, Hong Kong. Electronic address: · Laboratory of Neuropsychology and Laboratory of Social Cognitive Affective Neuroscience, Department of Psychology, University of Hong Kong, Hong Kong. Electronic address: · Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China; Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China. · Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Department of Radiology, The Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, Queen's University, School of Medicine, Kingston, ON, Canada. · Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, China. · Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hung Hom, Hong Kong. · Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China. · Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China; Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, China; The State Key Laboratory of Brain and Cognitive Sciences and Department of Ophthalmology, University of Hong Kong, Hong Kong. Electronic address: · Pubmed 31614176
2019
  • Post-Graduation Program in Psychiatry and Medical Psychology, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil; Research Group in Molecular and Behavioral Neuroscience of Mood Disorders, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil. · Post-Graduation Program in Psychiatry and Medical Psychology, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil; Research Group in Molecular and Behavioral Neuroscience of Mood Disorders, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil; Department of Psychiatry, Queen's University School of Medicine, Kingston, ON, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, Queen's University School of Medicine, Kingston, ON, Canada. · Department of Internal Medicine, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil; Unit of Endocrinology and Metabolism, Hospital de Clinicas de Porto Alegre, Porto Alegre, RS, Brazil. · Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; Department of Psychiatry and Centre for Neuroscience Studies, Queen's University, Kingston, ON, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada; Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Pubmed 31352032
  • Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, Canada; Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China. · Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo, São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, Canada. · Department of Organic Chemitry, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo, São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, Canada. Electronic address: · Pubmed 30904564
  • Allergan, Madison, N.J. (Earley, Burgess, Rekeda, Dickinson) · Gedeon Richter, Budapest, Hungary (Szatmári, Németh) · the Mood Disorders Psychopharmacology Unit, University Health Network, Toronto (McIntyre) · the Department of Psychiatry, Harvard Medical School, and the Bipolar Clinic and Research Program, Massachusetts General Hospital, Boston (Sachs) · and the Department of Psychiatry, University of British Columbia, Vancouver (Yatham). · Pubmed 30845817
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA. · Bipolar and Depression Research Program, VA Palo Alto Health Care System, Palo Alto, California, USA. · Clinical Development, Allergan, Madison, New Jersey, USA. · Medical Affairs, Allergan, Madison, New Jersey, USA. · Department of Psychiatry, University of California, San Diego, California, USA. · Pubmed 31576791
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Department of Psychiatry, University of Toronto, Toronto, Canada. · Department of Psychiatry, Queen's University, Kingston, Canada. · Department of Psychiatry, Research Group in Molecular and Behavioral Neurosciences of Mood Disorders, Universidade Federal de São Paulo, Sao Paulo, Brazil. · Brain and Cognition Discovery Foundation, Toronto, Canada. · Pubmed 31464359
  • Mood Disorders Psychopharmacology Unit, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada; Brain Cognition Discovery Foundation, Toronto, Ontario, Canada. Electronic address: · Centers of Psychiatric Excellence, New York, New York, United States. · Allergan plc, Madison, NJ, United States. · Pubmed 31344528
  • Mood Disorders Psychopharmacology Unit, University Health Network , Toronto , Canada. · University Hospitals Cleveland Medical Center , Cleveland , OH , USA. · Pubmed 31311335
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Laboratory of Neuropsychology, Laboratory of Social Cognitive Affective Neuroscience, Department of Psychology, The University of Hong Kong, Hong Kong, China. · Department of Psychology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), Guangzhou, China. · Academician workstation of Mood and Brain Sciences, Guangzhou Medical University, Guangzhou, China. · Laboratory of Emotion and Cognition, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Department of Psychology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. · GMH Institute of CNS Regeneration, Jinan University, Guangzhou, China. · The State Key Laboratory of Brain and Cognitive Sciences and Department of Ophthalmology, University of Hong Kong, Hong Kong, China. · Pubmed 31282606
  • a Department of Psychiatry and Pharmacology , University of Toronto , Toronto , Canada. · b Mood Disorders Psychopharmacology Unit, University Health Network , Toronto , Canada. · c Brain and Cognition Discovery Foundation , Toronto , Canada. · d Department of Psychiatry and Gastroenterology, McMaster University , Hamilton , Canada. · Pubmed 31132957
  • Copenhagen Affective Disorders Research Centre (CADIC), Psychiatric Center Copenhagen, Department O, 6243, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. · Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Copenhagen Affective Disorders Research Centre (CADIC), Psychiatric Center Copenhagen, Department O, 6243, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. · Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Clinical Metabolic Physiology, Steno Diabetes Center Copenhagen, Gentofte Hospital, Hellerup, Denmark. · Centre of Inflammation and Metabolism (CIM) and the Centre for Physical Activity Research (CFAS), Rigshospitalet, Copenhagen, Denmark. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Pubmed 30937579
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30795495
  • a Mood Disorders Psychopharmacology Unit , University Health Network , Toronto , Canada. · b Department of Psychiatry , University of Toronto , Toronto , Canada. · c Department of Pharmacology , University of Toronto , Toronto , Canada. · Pubmed 30753085
  • Department of Psychiatry, Federal University of São Paulo, SP, Brazil. · Department of Psychiatry, University of Toronto, ON, Canada; Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Brain and Cognition Discovery Foundation, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Federal University of São Paulo, SP, Brazil; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Pubmed 30611064
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: · Department of Psychiatry, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, United States. · Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Boston, MA, United States. · Neurocrine Biosciences, Inc., San Diego, CA, United States. · Pubmed 30583148
  • 1 The Copenhagen Affective Disorder Research Center (CADIC), Psychiatric Center Copenhagen, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. · 2 Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Pubmed 30518229
  • Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua 3 de maio 100, Ed. INFAR, 3rd floor, CEP 04044-020 São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua Pedro de Toledo, 669, 3rd floor, Vila Clementino, CEP 04039-032 São Paulo, Brazil. Electronic address: · Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua 3 de maio 100, Ed. INFAR, 3rd floor, CEP 04044-020 São Paulo, Brazil. Electronic address: · Pubmed 30321766
  • Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada. · Depression and Bipolar Support Alliance (DBSA), Chicago, IL, United States; Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States. · Depression and Bipolar Support Alliance (DBSA), Chicago, IL, United States. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada; Depression and Bipolar Support Alliance (DBSA), Chicago, IL, United States. Electronic address: · Pubmed 30241026
2018
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada. · Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychological Medicine, National University of Singapore, Singapore. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada Institute of Medical Science, University of Toronto, Toronto, ON, Canada Department of Psychiatry, University of Toronto, Toronto, ON, Canada Department of Pharmacology, University of Toronto, Toronto, ON, Canada. · Pubmed 30524702
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada; Department of Psychiatry, Federal University of São Paulo (Unifesp), São Paulo, Brazil. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. · Unitat Docent de Psiquiatria i Psicologia Mèdica, Departament de Medicina, Universitat de València, Valencia Unitat de Salut Mental de Catarroja, Valencia Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto Carlos III, Madrid International Society for Nutritional Psychiatry Research (ISNPR), Spain. · Psychiatric Centre Copenhagen, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. · Hospital Universitario de Alava-Santiago, CIBERSAM, EHU, Vitoria, Spain. · Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Department of Psychological Medicine, National University Health System, Singapore, Singapore. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada. · Pubmed 30075165
  • UHN-Toronto Western Hospital, Mood Disorders Psychopharmacology Unit, University of Toronto, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. · Department of Psychological Medicine, King's College London and South London and Maudsley NHS Foundation Trust, London, UK. · Neuroscience and Psychiatry Unit, University of Manchester, Manchester, UK. · Pubmed 29977518
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, Federal University of São Paulo, São Paulo 05403-903, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Department of Pharmacology, University of Toronto, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. · Pubmed 29673146
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Institute of Medical Science, University of Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. · Pubmed 29481915
  • Mood Disorder Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 29102836
  • Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil; Mood Disorders Psychpharmachology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), University of Toronto, Toronto, Canada. Electronic address: · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Mood Disorders Psychpharmachology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Pubmed 28830676
  • Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada. · Depression and Bipolar Support Alliance, Chicago, Illinois, USA. · Kaiser Permanente Washington Health Research Insitute, Seattle, Washington, USA. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, 399 Bathurst St, MP 9-325, Toronto, ON M5T 2S8, Canada. · Pubmed 30444959
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. Electronic address: · Department of Psychiatry and Behavioral Sciences, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, USA. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA. · Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; Centre for Neuroscience Studies, Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada. · Center for Neuroscience in Women's Health, Stanford University, Palo Alto, USA. · Laboratory of Neuroendocrinology, The Rockefeller University, New York, USA. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo, SP, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. · Pubmed 30391805
  • Mood Disorders Psychopharmacology Unit, University Health Network,Toronto, ON M5T 2S8 Canada;E-mail: · Pubmed 30372507
  • Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil. · Laboratory of Emotion and Cognition, Department of Affective Disorders, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China; Department of Neuropsychology, University of Hong Kong, Hong Kong, China. · School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Psychiatry, Chang Gung Memorial Hospital, Chiayi, Taiwan. · Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. · Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30153635
  • Johns Hopkins University and the Kennedy Krieger Institute, Baltimore, MD, USA, · Allergan, Madison, NJ, USA. · VA Palo Alto Health Care System, Palo Alto, CA, USA. · Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. · Toronto Western Research Institute, Toronto, ON, Canada. · Pubmed 30122926
  • Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK. · Centre for Affective Disorders, IoPPN, Kings College, London, UK. · Psychiatry Department, Santa Casa School of Medical Sciences, São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, Toronto, Ontario, Canada. · Pubmed 29888230
  • Medical University of Graz, Department of Psychiatry and Psychotherapeutic Medicine, Graz, Austria. · Medical University of Graz, Department of Psychiatry and Psychotherapeutic Medicine, Graz, Austria. Electronic address: · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Graz, Austria. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 29433074
  • Dent Neurologic Institute, Amherst, NY, USA. · University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, USA. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 29427512
  • Research Group of Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil; Post-Graduation Program in Psychiatry and Medical Psychology, Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), Toronto, ON, Canada. · Developmental Cognitive Neuroscience Laboratory (DCNL), Brain Institute (InsCer), Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil. · Santa Casa School of Medical Sciences of São Paulo, São Paulo, Brazil. · Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), Toronto, ON, Canada; Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Research Group of Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil; Post-Graduation Program in Psychiatry and Medical Psychology, Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), Toronto, ON, Canada. Electronic address: · Pubmed 29102835
  • Department of Psychiatry, Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital at Chiayi, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan. · School of Medicine, Chang Gung University, Taoyuan, Taiwan; Health Information and Epidemiology Laboratory, Chang Gung Memorial Hospital, Chiayi, Taiwan; Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University, College of Public Health, Taipei, Taiwan. · Health Information and Epidemiology Laboratory, Chang Gung Memorial Hospital, Chiayi, Taiwan. · University of California, San Francisco (UCSF), USA. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Canada; Department of Psychiatry, University of Toronto, Canada. · Department of Speech, Language Pathology and Audiology, Chung Shan Medical University, Taiwan. · Department of Medicine, Mackay Medical College, Taipei, Taiwan; Department of Psychiatry, Mackay Memorial Hospital, Taipei, Taiwan; Department of Audiology, Speech, and Language Pathology, Mackay Medical College, Taipei, Taiwan. Electronic address: · Pubmed 28972929
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28944976
  • Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada. · Grupo de Pesquisa em Neurociência Comportamental e Molecular do Transtorno Bipolar, Departamento de Psiquiatria, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Pubmed 30156658
2017
  • Department of Psychiatry, University of Toronto, Toronto, ON M5T 2S8, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 2S8, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada. · Pubmed 29084144
  • a Department of Psychiatry , University of Toronto , Toronto , Canada. · b Mood Disorders Psychopharmacology Unit , University Health Network , Toronto , Canada. · c Brain and Cognition Discovery Foundation , Toronto , Canada. · d Neuralstem , 20271 Goldenrod Lane, Germantown , MD 20876 , USA. · Pubmed 28460574
  • 1Department of Psychiatry,University of California,San Diego,California,USA. · 3Neuroscience Education Institute,Carlsbad,California,USA. · 4Lucio Bini Mood Disorders Center,New York,New York,USA. · 5Department of Psychiatry,Massachusetts General Hospital,Boston,Massachusetts,USA. · 6Department of Psychiatry,Icahn School of Medicine at Mount Sinai,New York,New York,USA. · 7Research Institute at the Lindner Center of HOPE,Mason,Ohio,USA. · 8Mood Disorders Psychopharmacology Unit,University Health Network,Toronto,Ontario,Canada. · 10Department of Psychiatry,University of Sydney,Sydney,Australia. · 11Centro Lucio Bini,Rome,Italy. · 12VA Palo Alto Health Care System,Palo Alto,California,USA. · 14Hospital Clinic,Institute of Neuroscience,University of Barcelona,IDIBAPS,CIBERSAM,Barcelona,Catalonia,Spain. · 15Psychiatry Clinic,Sainen,Kanazawa City,Ishikawa Prefecture,Japan. · 16Department of Psychiatry,Perelman School of Medicine,University of Pennsylvania, and the Corporal Michael J. Crescenz Veterans Affairs Medical Center,Philadelphia,Pennsylvania,USA. · 17Department of Psychological Medicine,Kings College,London,United Kingdom. · 18Department of Psychiatry,Rhode Island Hospital,Providence,Rhode Island,USA. · Pubmed 28421980
  • University of São Paulo (USP), São Paulo, Brazil; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. Electronic address: · Pubmed 28107669
  • Mood Disorder Psychopharmacology Unit,University Health Network,Department of Psychiatry,University of Toronto,Toronto,Ontario,Canada. · Pubmed 27618746
  • VA Palo Alto Health Care System and Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. · H. Lundbeck A/S, Valby, Copenhagen, Denmark. · Department of Clinical Sciences, Lund University, Lund, Sweden. · Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London, London, UK. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, ON, Canada. · Pubmed 29105003
  • Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, Kuwait University, Kuwait City, Kuwait. · Psychosocial Oncology Clinic, University Health Network, Toronto, ON, Canada. · Department of Psychology, University of Toronto, Toronto, ON, Canada. · Neuropsychology Clinic, University Health Network, Toronto, ON, Canada. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Department of Psychiatry, Women's College Hospital, Toronto, ON, Canada. · Department of Toxicology and Pharmacology, University of Toronto, Toronto, ON, Canada. · Pubmed 28599348
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology, University of Toronto, Ontario, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Laboratory of Emotion and Cognition, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28493605
  • Department of Psychiatry and Psychotherapy, Medical University of Graz, Graz, Austria. · Department of Psychiatry and Psychotherapy, Medical University of Graz, Graz, Austria. Electronic address: · Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria. · Division of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria. · Institute of Laboratory Medicine, Medical Center of Munich University (LMU), Munich, Germany. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 28482311
  • Department of Psychiatry, Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital at Chiayi, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Nursing, Chang Gung Institute of Technology, Taoyuan, Taiwan. · Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital at Chiayi, Taiwan. · School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Neurosurgery, Chang Gung Memorial Hospital at Chiayi, Taiwan. · Center of Excellence for Chang Gung Research Datalink, Chang Gung Memorial Hospital at Chiayi, Taiwan. · Center of Excellence for Chang Gung Research Datalink, Chang Gung Memorial Hospital at Chiayi, Taiwan; Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital, at Chiayi, Taiwan; Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University College of Public Health, Taipei, Taiwan. · Department of Psychiatry, Wan-Fang Hospital & School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. · Department of Neurology, Kaohsiung Medical University and Hospital, Kaohsiung, Taiwan. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Department of Psychiatry, Chung Shan Medical University Hospital, Taichung, Taiwan; Department of Psychiatry, School of Medicine, Chung Shan Medical University, Taichung, Taiwan. · Department of Psychiatry, Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital at Chiayi, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan. Electronic address: · Pubmed 28477503
  • Reserach Group in Behavioral and Molecular Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 28457001
  • Mood Disorders Psychopharmacology Unit,University Health Network,Toronto,Ontario,Canada. · Pubmed 28264727
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Division of Endocrinology, Mount Sinai Hospital, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Research Division, Institute of Mental Health, Singapore. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Department of Psychiatry, Stanford University, Palo Alto, CA, United States. · Department of Psychiatry, Dalhousie University, Halifax, Canada. · Pubmed 27721184
  • Mood Disorder Psychopharmacology Unit,University Health Network,Department of Psychiatry,University of Toronto,Toronto,Ontario,Canada. · Pubmed 27629159
2016
  • Departments of Psychiatry and Pharmacology, Mood Disorders Psychopharmacology Unit, University of Toronto, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada. · Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceará, Rua Prof. Costa Mendes, 1608, 4o andar, 60.430-140 Fortaleza, CE, Brazil. · Pubmed 26812953
  • 1Mood Disorders Psychopharmacology Unit,University Health Network,Toronto,Ontario,Canada. · Pubmed 28044944
  • Resident of Psychiatry, Clinician Scientist Stream, University of Toronto, Toronto, ON, Canada. · Resident of Psychiatry, Western University, London, ON, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Canada; Psychiatry and Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 27400335
  • Mood Disorders Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada. · Department of Psychiatry, Western University, London and Windsor, ON, Canada. · IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Vic., Australia. · Department of Psychiatry, The Florey Institute of Neuroscience and Mental Health, and Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, University of Melbourne, Parkville, Vic., Australia. · Psychiatric Center Copenhagen, Faculty of Health and Medical Sciences and Department O, University of Copenhagen, Copenhagen, Denmark. · Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, São Paulo, Brazil. · Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Departments of Psychiatry, Pharmacology, and Psychological Clinical Science, Centre for Youth Bipolar Disorder, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. · Pubmed 26990051
  • Mood Disorder Psychopharmacology Unit, University Health Network, University of Toronto, 399 Bathurst Street, MP 9-325, Toronto, Ontario M5T 2S8, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, University of Toronto, 399 Bathurst Street, MP 9-325, Toronto, Ontario M5T 2S8, Canada. Electronic address: · Pubmed 26876323
  • Research Division, Institute of Mental Health, Singapore, 10 Buangkok View, Singapore 539747, Singapore. · Department of General Psychiatry, Institute of Mental Health/Woodbridge Hospital, Singapore, 10 Buangkok View, Singapore 539747, Singapore. · Division of Psychiatry, Department of Molecular Medicine, University at Siena, Italy, Viale Bracci 1, 53100 Siena, Italy. · Mood Disorders Psychopharmacology Unit, University of Toronto, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada. · Bipolar Disorders Program, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain. · Research Division, Institute of Mental Health, Singapore, 10 Buangkok View, Singapore 539747, Singapore; Department of General Psychiatry, Institute of Mental Health/Woodbridge Hospital, Singapore, 10 Buangkok View, Singapore 539747, Singapore. Electronic address: · Pubmed 26691725
  • Merck, Whitehouse Station, NJ, USA. · Forest Research Institute (now Actavis), Jersey City, NJ, USA. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, ON, Canada. · Forest Research Institute (now Actavis), Jersey City, NJ, USA. Electronic address: · Pubmed 26496015
  • Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 27488494
  • Faculty of Kinesiology and Physical Education, University of Toronto, 55 Harbord Street, Toronto, ON, M5S2W6, Canada. · School of Kinesiology, University of British Columbia, 2146 Health Sciences Mall, Room 4606, Vancouver, BC, V6T 1Z3, Canada. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON, M5T 2S8, Canada. · Schizophrenia Program Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada. · School of Kinesiology, University of British Columbia, 2146 Health Sciences Mall, Room 4606, Vancouver, BC, V6T 1Z3, Canada. · Pubmed 27405745
  • Department of Psychiatry, Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Bipolar Disorder Program and Laboratory of Molecular Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · Pubmed 27324989
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 27281261
  • Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Centre for Research in Occupational Safety and Health, Laurentian University, Sudbury, Ontario, Canada. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; University Health Network in Toronto, Ontario, Canada. · University of Calgary in Calgary, Alberta, Canada. · Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · University of British Columbia, Vancouver, British Columbia, Canada. · Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 27182964
  • Department of Psychiatry, Medical University of Graz, Graz, Austria. · Department of Psychology, Karl-Franzens University of Graz, Graz, Austria. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria. · Division of Biological Chemistry, Innsbruck Medical University, Innsbruck, Austria. · Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich, Germany. · Pubmed 27016286
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26866976
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26748249
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Cleveland Clinic, Cleveland, OH, USA. · Turn2Health Solutions, Willoughby, OH, USA. · Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil. · Department of Neuropsychiatry, University of South Carolina School of Medicine, USA. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26508286
2015
  • Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26363613
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 25579847
  • Department of Psychiatry, Medical University of Graz, Graz, Austria. · Department of Neurology, Medical University of Graz, Graz, Austria. · Department of Neurology, Medical University of Graz, Graz, Austria; Division of Neuroradiology, Department of Radiology, Medical University of Graz, Graz, Austria. · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Graz, Austria. · Division of Neuroradiology, Department of Radiology, Medical University of Graz, Graz, Austria. · Mood Disorders Psychopharmacology Unit at the University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26252714
  • Professor of Psychiatry and Pharmacology, Head, Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, Ontario, Canada. · Pubmed 26172636
  • Psychiatric Center Copenhagen, Department O and University of Copenhagen Denmark. Electronic address: · Department of Biostatistics University of Copenhagen Copenhagen, Denmark. · Department of Psychiatry and Pharmacology University of Toronto, Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ont., Canada. · Pubmed 25909752
  • University of Toronto, Departments of Psychiatry and Pharmacology, Mood Disorders Psychopharmacology Unit, 399 Bathurst St, MP 9-325, Toronto, ON, Canada M5T 2S8 · Pubmed 25844756
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Cleveland Clinic, Cleveland, OH, USA. · Medco Health Solutions, Inc, Fort Worth, TX, USA. · Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 25451425
  • Department of Psychiatry, Medical University of Graz, Graz, Austria. · Institute of Pathophysiology and Immunology, Medical University of Graz, Austria. · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Auenbruggerplatz 15, 8043 Graz, Austria. · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Auenbruggerplatz 15, 8043 Graz, Austria; BioTechMed-Graz, Austria. Electronic address: · Division of Biological Chemistry, Innsbruck Medical University, Innsbruck, Austria. · Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada; Department of Psychiatry and Pharmacology at the University of Toronto, Toronto, Canada. · Pubmed 25443762
2014
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 25090934
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Department of Morphology and Genetics, Federal University of São Paulo, São Paulo, Brazil. · Institute of Biomedical Research and Faculty of Biosciences, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Pubmed 24548785
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Schulich School of Medicine and Dentistry, Western University, London, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 24468642
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 24330342
  • University of New Mexico, Health Sciences Center, Department of Psychiatry, Albuquerque, NM, USA. · University of Toronto, Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Kyushu University, Department of Neuropsychiatry, Fukuoka, Japan; East Asian Bipolar Forum, Fukuoka, Japan. · Eli Lilly Japan K.K., Lilly Research Laboratories, Statistical Science, Kobe, Japan. · Eli Lilly Japan K.K., Lilly Research Laboratories, Medical Science, Sannomiya Plaza Building, 7-1-5, Isogamidori, Chuo-ku, Kobe 651-0086, Japan. Electronic address: · Pubmed 25046739
  • University of New Mexico, Health Sciences Center, Department of Psychiatry, Albuquerque, NM, USA. · Kyushu University, Department of Neuropsychiatry, Fukuoka, Japan; East Asian Bipolar Forum, Fukuoka, Japan. · University of Toronto, Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Eli Lilly Japan K. K., Lilly Research Laboratories, Statistical Science, Kobe, Japan. · Eli Lilly Japan K. K., Lilly Research Laboratories, Medical Science, Kobe, Japan. Electronic address: · Pubmed 24856554
  • Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil; Department of Clinical Medicine, Faculty of Medicine, Fortaleza, Ceará, Brazil. Electronic address: · Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil. · Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil; Department of Clinical Medicine, Faculty of Medicine, Fortaleza, Ceará, Brazil. · Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil; Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, Ceará, Brazil. · 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. · Mood Disorders Unit (GRUDA), Department and Institute of Psychiatry, School of Medicine, University of Sao Paulo (IPq-HC-FMUSP), Brazil. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, School of Medicine, University of Ioannina, Ioannina, Greece. · Pubmed 24767016
2013
  • Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada; Department of Psychiatry, University Health Network, Toronto, Canada. · Pubmed 24014142
2012
  • Mood Disorders Psychopharmacology Unit, University Health Network, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Pubmed 22563572
  • Mood Disorders Psychopharmacology Unit, University Health Network, Departments of Psychiatry and Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 22303523
  • University Health Network, Mood Disorders Psychopharmacology Unit, 399 Bathurst Street, Toronto, Ontario, M5T 2S8, Canada. · Pubmed 22559286
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 22510034
  • Department of Psychiatry, University of Toronto, Toronto, Canada. · Pubmed 22182459
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 23107220
  • University of Toronto, Canada University Health Network, Canada. · Pubmed 22849038
2011
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 20950326
  • Department of Psychiatry, University of Toronto, and Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Pubmed 21450149
2010
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 20541810
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 20420486
  • Department of Psychiatry, University of Toronto, Canada. · Pubmed 20152551
  • Department of Psychiatry, University of Toronto, ON, Canada. · Pubmed 20878373
  • Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, ON, Canada. · Pubmed 20537396
  • University of Toronto, Toronto, ON, Canada M5T 2S8. · Pubmed 20096936
2018
  • University of Toronto, Toronto, Canada. · Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada. · Depression and Bipolar Support Alliance (DBSA), Chicago, Illinois. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Guangzhou Medical University, Guangzhou, China. · College of Medicine, Korea University, Seoul, Republic of Korea. · Pubmed 30412345
2014
  • Centre for Neuroscience Studies, Queen's University, Kingston, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Pubmed 24467470
2013
  • Mood Disorders Psychopharmacology Unit, University Health Network, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. · Pubmed 23839119
2010
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Pubmed 21084787
  • Division of Neurosurgery, University Health Network Department of Psychiatry, University of Toronto, University Health Network, 399 Bathurst Street, Toronto, Ontario, Canada. · Pubmed 21040286
  • University of Toronto, Ontario, Canada. · Pubmed 20840804
Probable:    Guangzhou Medical University      
2020
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China; Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China; Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, China; Laboratory of Neuropsychology and Laboratory of Social Cognitive Affective Neuroscience, Department of Psychology, University of Hong Kong, Hong Kong. Electronic address: · Laboratory of Neuropsychology and Laboratory of Social Cognitive Affective Neuroscience, Department of Psychology, University of Hong Kong, Hong Kong. Electronic address: · Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China; Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China. · Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Department of Radiology, The Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, Queen's University, School of Medicine, Kingston, ON, Canada. · Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, China. · Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hung Hom, Hong Kong. · Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China. · Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China; Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, China; The State Key Laboratory of Brain and Cognitive Sciences and Department of Ophthalmology, University of Hong Kong, Hong Kong. Electronic address: · Pubmed 31614176
2019
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Laboratory of Neuropsychology, Laboratory of Social Cognitive Affective Neuroscience, Department of Psychology, The University of Hong Kong, Hong Kong, China. · Department of Psychology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), Guangzhou, China. · Academician workstation of Mood and Brain Sciences, Guangzhou Medical University, Guangzhou, China. · Laboratory of Emotion and Cognition, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Department of Psychology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. · GMH Institute of CNS Regeneration, Jinan University, Guangzhou, China. · The State Key Laboratory of Brain and Cognitive Sciences and Department of Ophthalmology, University of Hong Kong, Hong Kong, China. · Pubmed 31282606
2018
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28944976
2017
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology, University of Toronto, Ontario, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Laboratory of Emotion and Cognition, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28493605
2018
  • University of Toronto, Toronto, Canada. · Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada. · Depression and Bipolar Support Alliance (DBSA), Chicago, Illinois. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Guangzhou Medical University, Guangzhou, China. · College of Medicine, Korea University, Seoul, Republic of Korea. · Pubmed 30412345
Probable:    University of Toronto   Contact    
2019
  • Copenhagen Affective Disorder Research Centre (CADIC), Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Department of Psychology, University of Copenhagen, Copenhagen, Denmark. · Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA. · Department of Psychiatry, Harvard Medical School, Boston, MA, USA. · Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain. · Department of Psychology, Queen's University, Kingston, Canada. · Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, Canada. · Institute of Neuroscience, Newcastle University, Newcastle-upon-Tyne, UK. · Psychiatry Research Unit, University of Fribourg, Fribourg, Switzerland. · Bipolar Disorder Research Program, Departamento de Psiquiatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, Brazil. · Research Group in Psychiatry, Department of Psychiatry, Universidad de Antioquia, Medellín, Colombia. · Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan. · Mood Disorders Psychopharmacology Unit Brain and Cognition Discovery Foundation, University of Toronto, Toronto, Canada. · Department of Psychological Medicine, University of Otago, Christchurch, New Zealand. · Department of Psychiatry, University of Alberta, Edmonton, Canada. · Department of Psychiatry, University of British Columbia, Vancouver, Canada. · Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. · Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne, Carlton, Australia. · Centre for Mental Health, Faculty of Health, Arts and Design, Swinburne University, Australia. · Pubmed 31491048
  • Laboratory of Molecular Psychiatry and Bipolar Disorder Program, Programa de Pós-Graduação em Psiquiatria e Ciências do Comportamento, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · School of Technology, Pontifícia Universidade Católica do Rio Grande do Sul, Rio Grande do Sul, Brazil. · Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada. · Department of Psychiatry and Behavioral Sciences, UT Center of Excellence on Mood Disorders, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA. · Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Department of Psychiatry, Queen's University School of Medicine, Kingston, ON, Canada. · Department of Psychiatry, Dalhousie University, Halifax, NS, Canada. · National Institute of Mental Health, Klecany, Czech Republic. · Research Group in Psychiatry, Department of Psychiatry, Faculty of Medicine, University of Antioquia, Medellín, Colombia. · Mood Disorders Program, Hospital Universitario San Vicente Fundación, Medellín, Colombia. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. · Department of Psychiatry, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. · Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Copenhagen Affective Disorder Research Center (CADIC), Psychiatric Center Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark. · Pubmed 31465619
  • Post-Graduation Program in Psychiatry and Medical Psychology, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil; Research Group in Molecular and Behavioral Neuroscience of Mood Disorders, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil. · Post-Graduation Program in Psychiatry and Medical Psychology, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil; Research Group in Molecular and Behavioral Neuroscience of Mood Disorders, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil; Department of Psychiatry, Queen's University School of Medicine, Kingston, ON, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, Queen's University School of Medicine, Kingston, ON, Canada. · Department of Internal Medicine, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil; Unit of Endocrinology and Metabolism, Hospital de Clinicas de Porto Alegre, Porto Alegre, RS, Brazil. · Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; Department of Psychiatry and Centre for Neuroscience Studies, Queen's University, Kingston, ON, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada; Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Pubmed 31352032
  • Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: · Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. · University of Toronto, Toronto, Canada. · University of Toronto, Toronto, Canada; MDPU, BCDF, UHN, Toronto, Ontario, USA. · Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA; VA Palo Alto Health Care System, Palo Alto, CA, USA. · Pubmed 30954775
  • Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, Canada; Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China. · Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo, São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, Canada. · Department of Organic Chemitry, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo, São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, Canada. Electronic address: · Pubmed 30904564
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Department of Psychiatry, University of Toronto, Toronto, Canada. · Department of Psychiatry, Queen's University, Kingston, Canada. · Department of Psychiatry, Research Group in Molecular and Behavioral Neurosciences of Mood Disorders, Universidade Federal de São Paulo, Sao Paulo, Brazil. · Brain and Cognition Discovery Foundation, Toronto, Canada. · Pubmed 31464359
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Laboratory of Neuropsychology, Laboratory of Social Cognitive Affective Neuroscience, Department of Psychology, The University of Hong Kong, Hong Kong, China. · Department of Psychology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), Guangzhou, China. · Academician workstation of Mood and Brain Sciences, Guangzhou Medical University, Guangzhou, China. · Laboratory of Emotion and Cognition, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Department of Psychology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. · GMH Institute of CNS Regeneration, Jinan University, Guangzhou, China. · The State Key Laboratory of Brain and Cognitive Sciences and Department of Ophthalmology, University of Hong Kong, Hong Kong, China. · Pubmed 31282606
  • a Department of Psychiatry and Pharmacology , University of Toronto , Toronto , Canada. · b Mood Disorders Psychopharmacology Unit, University Health Network , Toronto , Canada. · c Brain and Cognition Discovery Foundation , Toronto , Canada. · d Department of Psychiatry and Gastroenterology, McMaster University , Hamilton , Canada. · Pubmed 31132957
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30795495
  • a Mood Disorders Psychopharmacology Unit , University Health Network , Toronto , Canada. · b Department of Psychiatry , University of Toronto , Toronto , Canada. · c Department of Pharmacology , University of Toronto , Toronto , Canada. · Pubmed 30753085
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: · Department of Psychiatry, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, United States. · Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Boston, MA, United States. · Neurocrine Biosciences, Inc., San Diego, CA, United States. · Pubmed 30583148
  • Department of Psychiatry,Dokuz Eylul University School of Medicine,Izmir,Turkey. · Department of Psychiatry,University of Toronto,Toronto, ON,Canada. · Pubmed 30326979
  • Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua 3 de maio 100, Ed. INFAR, 3rd floor, CEP 04044-020 São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua Pedro de Toledo, 669, 3rd floor, Vila Clementino, CEP 04039-032 São Paulo, Brazil. Electronic address: · Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua 3 de maio 100, Ed. INFAR, 3rd floor, CEP 04044-020 São Paulo, Brazil. Electronic address: · Pubmed 30321766
  • Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada. · Depression and Bipolar Support Alliance (DBSA), Chicago, IL, United States; Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States. · Depression and Bipolar Support Alliance (DBSA), Chicago, IL, United States. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada; Depression and Bipolar Support Alliance (DBSA), Chicago, IL, United States. Electronic address: · Pubmed 30241026
2018
  • Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA. · Department of Psychiatry, University of Minnesota, Minneapolis, MN, USA. · Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada. · Departments of Psychiatry and Obstetrics & Gynaecology, Western University, London, ON, Canada. · Department of Psychiatry, McGill University, Montreal, QC, Canada. · Department of Psychiatry, Dalhousie University, Halifax, NS, Canada. · Department of Psychiatry, University of Calgary, Calgary, AB, Canada. · Departments of Psychiatry and Psychology, Queen's University, Kingston, ON, Canada. · School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada. · Department of Neuropsychiatry, Kyushu University, Fukuoka, Japan. · Department of Psychiatry, University of Sao Paulo, Sao Paulo, Brazil. · Bipolar and Depression Research Program, VA Palo Alto, Department of Psychiatry & Behavioral Sciences Stanford University, Stanford, CA, USA. · Department of Psychiatry, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH, USA. · Bipolar Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain. · Department of Psychiatry, University of Sydney, Sydney, NSW, Australia. · Department of Psychiatry, George Washington University, Washington, DC, USA. · Deakin Univeristy, IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Geelong, Vic., Australia. · Pubmed 29536616
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada. · Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychological Medicine, National University of Singapore, Singapore. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada Institute of Medical Science, University of Toronto, Toronto, ON, Canada Department of Psychiatry, University of Toronto, Toronto, ON, Canada Department of Pharmacology, University of Toronto, Toronto, ON, Canada. · Pubmed 30524702
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada; Department of Psychiatry, Federal University of São Paulo (Unifesp), São Paulo, Brazil. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. · Unitat Docent de Psiquiatria i Psicologia Mèdica, Departament de Medicina, Universitat de València, Valencia Unitat de Salut Mental de Catarroja, Valencia Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto Carlos III, Madrid International Society for Nutritional Psychiatry Research (ISNPR), Spain. · Psychiatric Centre Copenhagen, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. · Hospital Universitario de Alava-Santiago, CIBERSAM, EHU, Vitoria, Spain. · Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Department of Psychological Medicine, National University Health System, Singapore, Singapore. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada. · Pubmed 30075165
  • UHN-Toronto Western Hospital, Mood Disorders Psychopharmacology Unit, University of Toronto, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. · Department of Psychological Medicine, King's College London and South London and Maudsley NHS Foundation Trust, London, UK. · Neuroscience and Psychiatry Unit, University of Manchester, Manchester, UK. · Pubmed 29977518
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, Federal University of São Paulo, São Paulo 05403-903, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Department of Pharmacology, University of Toronto, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. · Pubmed 29673146
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Institute of Medical Science, University of Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. · Pubmed 29481915
  • Mood Disorder Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 29102836
  • Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil; Mood Disorders Psychpharmachology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), University of Toronto, Toronto, Canada. Electronic address: · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Mood Disorders Psychpharmachology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Pubmed 28830676
  • Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada. · Depression and Bipolar Support Alliance, Chicago, Illinois, USA. · Kaiser Permanente Washington Health Research Insitute, Seattle, Washington, USA. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, 399 Bathurst St, MP 9-325, Toronto, ON M5T 2S8, Canada. · Pubmed 30444959
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. Electronic address: · Department of Psychiatry and Behavioral Sciences, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, USA. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA. · Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; Centre for Neuroscience Studies, Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada. · Center for Neuroscience in Women's Health, Stanford University, Palo Alto, USA. · Laboratory of Neuroendocrinology, The Rockefeller University, New York, USA. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo, SP, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. · Pubmed 30391805
  • 1 School of Psychiatry - University of New South Wales and Black Dog Institute, Randwick, NSW, Australia. · 2 Department of Psychiatry, University of Calgary, Calgary, AB, Canada. · 3 IMPACT SRC, School of Medicine, Barwon Health, Deakin University, Geelong, VIC, Australia. · 4 Department of Psychiatry, Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health and the Florey Institute for Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia. · 5 Allgemeinpsychiatrie Ost, Klinikum am Weissenhof, Weinsberg, Germany. · 6 Paracelsus Medical Private University (PMU) Nuremberg, Nuremberg, Germany. · 7 Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · 8 Center for Anxiety & Depression, Mercer Island, WA, USA. · 9 Department of Psychiatry & Behavioral Sciences, University of Washington, Seattle, WA, USA. · 10 School of Medicine, Case Western Reserve University, Cleveland, OH, USA. · 11 Depression Research Unit, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · 12 Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. · 13 Department of Psychiatry, The University of British Columbia, Vancouver, BC, Canada. · 14 The Copenhagen Affective Disorder Research Center (CADIC), Psychiatric Center Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark. · 15 Division of Psychiatry, School of Medicine, The University of Western Australia, Perth, WA, Australia. · 16 Department of Psychiatry and Human Behavior, Brown University, and Rhode Island Hospital, Providence, RI, USA. · 17 3rd Department of Psychiatry, Division of Neurosciences, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. · 18 Department of Psychiatry, Queen's University, Kingston, ON, Canada. · 19 Department of Psychiatry, Dalhousie University, Halifax, NS, Canada. · 20 Departments of Psychiatry and Medical Neuroscience, Dalhousie University, Halifax, NS, Canada. · 21 Department of Psychiatry, Western University, London, ON, Canada. · 22 Center for Behavioral Health, Cleveland Clinic, Cleveland, OH, USA. · 23 Discipline of Psychiatry, Westmead Clinical School, Sydney Medical School, University of Sydney, Westmead, NSW, Australia. · 24 Mood Disorders Program, Department of Psychiatry and Behavioural Neurosciences, McMaster University and Women's Health Concerns Clinic, St. Joseph's Healthcare, Hamilton, ON, Canada. · 25 The University of Melbourne and St Vincent's Hospital, Melbourne, VIC, Australia. · 26 The Centre for Affective Disorders, King's College London, London, UK. · 27 Hospital Clinic of Barcelona, Clinic Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain. · 28 Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland. · 29 Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. · 30 Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · 31 Centre for Mental Health, Swinburne University of Technology, Melbourne, VIC, Australia. · 32 Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne, Carlton, VIC, Australia. · 33 Department of Psychiatry, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey. · 34 School of Medicine & Health Sciences, The George Washington University, Washington, DC, USA. · 35 Bipolar Collaborative Network, Bethesda, MD, USA. · 36 Department of Psychiatry, VA Palo Alto Health Care System, Palo Alto, CA, USA. · 37 Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. · 38 Department of Psychiatry, School of Medicine, University of São Paulo, São Paulo, Brazil. · 39 Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London, London, UK. · 40 Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · 41 AP-HP, Hôpitaux Universitaires Henri Mondor, DHU Pepsy, Pôle de Psychiatrie et d'Addictologie, Université Paris-Est Créteil Val de Marne, Créteil, France. · 42 Department of Neuropsychiatry, Kyushu University, Fukuoka, Japan. · 43 Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA. · 44 Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA. · 45 New York State Psychiatric Institute, Columbia University, New York, NY, USA. · 46 Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · 47 Open Sky Psychology, Ryde, NSW, Australia. · 48 Veterans Affairs Boston Healthcare System, Harvard Medical School, Boston, MA, USA. · 49 Department of Psychiatry and Psychology, Mayo Clinic College of Medicine, Rochester, MN, USA. · 50 Department of Psychiatry, University of Toronto and Brain and Cognition Discovery Foundation, Toronto, ON, Canada. · 51 Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy. · 52 Psychology Clinic, University of New South Wales, Sydney, NSW, Australia. · 53 Psychology Clinic, Black Dog Institute, Randwick, NSW, Australia. · 54 Department of Psychiatry and Behavioral Health, Stony Brook University School of Medicine, Stony Brook, NY, USA. · 55 CADE Clinic, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, NSW, Australia. · 56 Academic Department of Psychiatry, Northern Sydney Local Health District, St Leonards, NSW, Australia. · 57 Discipline of Psychiatry, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 30378461
  • Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil. · Laboratory of Emotion and Cognition, Department of Affective Disorders, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China; Department of Neuropsychology, University of Hong Kong, Hong Kong, China. · School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Psychiatry, Chang Gung Memorial Hospital, Chiayi, Taiwan. · Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. · Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30153635
  • Johns Hopkins University and the Kennedy Krieger Institute, Baltimore, MD, USA, · Allergan, Madison, NJ, USA. · VA Palo Alto Health Care System, Palo Alto, CA, USA. · Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. · Toronto Western Research Institute, Toronto, ON, Canada. · Pubmed 30122926
  • Case Management Unit, Institute of Mental Health, Singapore. · Department of General and Forensic Psychiatry, Institute of Mental Health, Singapore. · Research Division, Institute of Mental Health, Singapore. · Department of General Psychiatry, Institute of Mental Health, Singapore. · Department of Psychiatry and Psychology, Institute of Neuroscience, University of Barcelona, IDIBAPS0-CIBERSAM, Barcelona, Spain. · Departments of Psychiatry and Pharmacology and Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of General Psychiatry, Institute of Mental Health/Woodbridge Hospital 10, Buangkok View, Singapore 539747. · Pubmed 29727072
  • Medical University of Graz, Department of Psychiatry and Psychotherapeutic Medicine, Graz, Austria. · Medical University of Graz, Department of Psychiatry and Psychotherapeutic Medicine, Graz, Austria. Electronic address: · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Graz, Austria. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 29433074
  • Dent Neurologic Institute, Amherst, NY, USA. · University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, USA. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 29427512
  • Department of Psychiatry, Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital at Chiayi, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan. · School of Medicine, Chang Gung University, Taoyuan, Taiwan; Health Information and Epidemiology Laboratory, Chang Gung Memorial Hospital, Chiayi, Taiwan; Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University, College of Public Health, Taipei, Taiwan. · Health Information and Epidemiology Laboratory, Chang Gung Memorial Hospital, Chiayi, Taiwan. · University of California, San Francisco (UCSF), USA. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Canada; Department of Psychiatry, University of Toronto, Canada. · Department of Speech, Language Pathology and Audiology, Chung Shan Medical University, Taiwan. · Department of Medicine, Mackay Medical College, Taipei, Taiwan; Department of Psychiatry, Mackay Memorial Hospital, Taipei, Taiwan; Department of Audiology, Speech, and Language Pathology, Mackay Medical College, Taipei, Taiwan. Electronic address: · Pubmed 28972929
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28944976
  • Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada. · Grupo de Pesquisa em Neurociência Comportamental e Molecular do Transtorno Bipolar, Departamento de Psiquiatria, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Pubmed 30156658
2017
  • Department of Psychiatry, University of Toronto, Toronto, ON M5T 2S8, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 2S8, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada. · Pubmed 29084144
  • Department of Psychiatry, Texas Tech University Health Sciences Center Medical School, Midland, Texas, USA. · Department of Neuropsychiatry and Behavioral Sciences, University of South Carolina School of Medicine, Greer, South Carolina, USA. · Mood Disorders Psychopharmacology Unit, University of Toronto, Ontario, Canada. · Pubmed 28994900
  • a Department of Psychiatry , University of Toronto , Toronto , Canada. · b Mood Disorders Psychopharmacology Unit , University Health Network , Toronto , Canada. · c Brain and Cognition Discovery Foundation , Toronto , Canada. · d Neuralstem , 20271 Goldenrod Lane, Germantown , MD 20876 , USA. · Pubmed 28460574
  • University of São Paulo (USP), São Paulo, Brazil; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. Electronic address: · Pubmed 28107669
  • Mood Disorder Psychopharmacology Unit,University Health Network,Department of Psychiatry,University of Toronto,Toronto,Ontario,Canada. · Pubmed 27618746
  • VA Palo Alto Health Care System and Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. · H. Lundbeck A/S, Valby, Copenhagen, Denmark. · Department of Clinical Sciences, Lund University, Lund, Sweden. · Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London, London, UK. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, ON, Canada. · Pubmed 29105003
  • Department of Psychiatry, Psychiatric Center Copenhagen, Copenhagen, Denmark. · Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. · Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark. · Department of Biostatistics, University of Copenhagen, Copenhagen, Denmark. · Department of Applied Mathematics and Computer Science, Technical University of Denmark, Kongens Lyngby, Denmark. · Gene Regulation Bioinformatics at the Bioinformatics Centre, Department of Biology/BRIC, University of Copenhagen, Copenhagen, Denmark. · The Centre of Inflammation and Metabolism at Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark. · Laboratory of Clinical Pharmacology, Rigshospitalet, Copenhagen, Denmark. · Department of Psychiatry and Pharmacology, University of Toronto, Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada. · McMaster University, Hamilton, Ontario, Canada. · Department and Institute of Psychiatry, and Laboratory of Neuroscience (LIM27), University of São Paulo Medical School, São Paulo, Brazil. · IT University Copenhagen, Copenhagen, Denmark. · Create-Net: Center for Research and Telecommunications Experimentation for Networked Communities, Trento, Italy. · Neurobiology Research Unit and Center for Integrated Molecular Brain Imaging, Rigshospitalet, Copenhagen, Denmark. · Department of Psychiatry, University of Pittsburgh, Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, USA. · Pubmed 28645967
  • Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, Kuwait University, Kuwait City, Kuwait. · Psychosocial Oncology Clinic, University Health Network, Toronto, ON, Canada. · Department of Psychology, University of Toronto, Toronto, ON, Canada. · Neuropsychology Clinic, University Health Network, Toronto, ON, Canada. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Department of Psychiatry, Women's College Hospital, Toronto, ON, Canada. · Department of Toxicology and Pharmacology, University of Toronto, Toronto, ON, Canada. · Pubmed 28599348
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology, University of Toronto, Ontario, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Laboratory of Emotion and Cognition, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28493605
  • Department of Psychiatry and Psychotherapy, Medical University of Graz, Graz, Austria. · Department of Psychiatry and Psychotherapy, Medical University of Graz, Graz, Austria. Electronic address: · Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria. · Division of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria. · Institute of Laboratory Medicine, Medical Center of Munich University (LMU), Munich, Germany. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 28482311
  • Department of Psychiatry, Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital at Chiayi, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Nursing, Chang Gung Institute of Technology, Taoyuan, Taiwan. · Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital at Chiayi, Taiwan. · School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Neurosurgery, Chang Gung Memorial Hospital at Chiayi, Taiwan. · Center of Excellence for Chang Gung Research Datalink, Chang Gung Memorial Hospital at Chiayi, Taiwan. · Center of Excellence for Chang Gung Research Datalink, Chang Gung Memorial Hospital at Chiayi, Taiwan; Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital, at Chiayi, Taiwan; Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University College of Public Health, Taipei, Taiwan. · Department of Psychiatry, Wan-Fang Hospital & School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. · Department of Neurology, Kaohsiung Medical University and Hospital, Kaohsiung, Taiwan. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Department of Psychiatry, Chung Shan Medical University Hospital, Taichung, Taiwan; Department of Psychiatry, School of Medicine, Chung Shan Medical University, Taichung, Taiwan. · Department of Psychiatry, Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital at Chiayi, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan. Electronic address: · Pubmed 28477503
  • Reserach Group in Behavioral and Molecular Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 28457001
  • University of Toronto, MDPU-BCDF, Toronto, Canada. · Sunovion Pharmaceuticals Inc., Marlborough, MA, USA. Electronic address: · Vertex Pharmaceuticals Inc., Boston, MA, USA. · Optum, Prairie, MN, USA. · Kantar Health, New York, NY, USA. · Sunovion Pharmaceuticals Inc., Marlborough, MA, USA. · Sunovion Pharmaceuticals Inc., Fort Lee, NY, USA. · Pubmed 28073041
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Division of Endocrinology, Mount Sinai Hospital, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Research Division, Institute of Mental Health, Singapore. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Department of Psychiatry, Stanford University, Palo Alto, CA, United States. · Department of Psychiatry, Dalhousie University, Halifax, Canada. · Pubmed 27721184
  • Mood Disorder Psychopharmacology Unit,University Health Network,Department of Psychiatry,University of Toronto,Toronto,Ontario,Canada. · Pubmed 27629159
2016
  • Departments of Psychiatry and Pharmacology, Mood Disorders Psychopharmacology Unit, University of Toronto, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada. · Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceará, Rua Prof. Costa Mendes, 1608, 4o andar, 60.430-140 Fortaleza, CE, Brazil. · Pubmed 26812953
  • Resident of Psychiatry, Clinician Scientist Stream, University of Toronto, Toronto, ON, Canada. · Resident of Psychiatry, Western University, London, ON, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Canada; Psychiatry and Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 27400335
  • Mood Disorders Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada. · Department of Psychiatry, Western University, London and Windsor, ON, Canada. · IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Vic., Australia. · Department of Psychiatry, The Florey Institute of Neuroscience and Mental Health, and Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, University of Melbourne, Parkville, Vic., Australia. · Psychiatric Center Copenhagen, Faculty of Health and Medical Sciences and Department O, University of Copenhagen, Copenhagen, Denmark. · Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, São Paulo, Brazil. · Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Departments of Psychiatry, Pharmacology, and Psychological Clinical Science, Centre for Youth Bipolar Disorder, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. · Pubmed 26990051
  • Mood Disorder Psychopharmacology Unit, University Health Network, University of Toronto, 399 Bathurst Street, MP 9-325, Toronto, Ontario M5T 2S8, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, University of Toronto, 399 Bathurst Street, MP 9-325, Toronto, Ontario M5T 2S8, Canada. Electronic address: · Pubmed 26876323
  • Research Division, Institute of Mental Health, Singapore, 10 Buangkok View, Singapore 539747, Singapore. · Department of General Psychiatry, Institute of Mental Health/Woodbridge Hospital, Singapore, 10 Buangkok View, Singapore 539747, Singapore. · Division of Psychiatry, Department of Molecular Medicine, University at Siena, Italy, Viale Bracci 1, 53100 Siena, Italy. · Mood Disorders Psychopharmacology Unit, University of Toronto, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada. · Bipolar Disorders Program, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain. · Research Division, Institute of Mental Health, Singapore, 10 Buangkok View, Singapore 539747, Singapore; Department of General Psychiatry, Institute of Mental Health/Woodbridge Hospital, Singapore, 10 Buangkok View, Singapore 539747, Singapore. Electronic address: · Pubmed 26691725
  • Merck, Whitehouse Station, NJ, USA. · Forest Research Institute (now Actavis), Jersey City, NJ, USA. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, ON, Canada. · Forest Research Institute (now Actavis), Jersey City, NJ, USA. Electronic address: · Pubmed 26496015
  • Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 27488494
  • Faculty of Kinesiology and Physical Education, University of Toronto, 55 Harbord Street, Toronto, ON, M5S2W6, Canada. · School of Kinesiology, University of British Columbia, 2146 Health Sciences Mall, Room 4606, Vancouver, BC, V6T 1Z3, Canada. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON, M5T 2S8, Canada. · Schizophrenia Program Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada. · School of Kinesiology, University of British Columbia, 2146 Health Sciences Mall, Room 4606, Vancouver, BC, V6T 1Z3, Canada. · Pubmed 27405745
  • Department of Psychiatry, Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Bipolar Disorder Program and Laboratory of Molecular Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · Pubmed 27324989
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 27281261
  • Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Centre for Research in Occupational Safety and Health, Laurentian University, Sudbury, Ontario, Canada. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; University Health Network in Toronto, Ontario, Canada. · University of Calgary in Calgary, Alberta, Canada. · Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · University of British Columbia, Vancouver, British Columbia, Canada. · Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 27182964
  • Department of Psychiatry, Medical University of Graz, Graz, Austria. · Department of Psychology, Karl-Franzens University of Graz, Graz, Austria. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria. · Division of Biological Chemistry, Innsbruck Medical University, Innsbruck, Austria. · Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich, Germany. · Pubmed 27016286
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26866976
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26748249
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Cleveland Clinic, Cleveland, OH, USA. · Turn2Health Solutions, Willoughby, OH, USA. · Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil. · Department of Neuropsychiatry, University of South Carolina School of Medicine, USA. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26508286
2015
  • Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26363613
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 25579847
  • (a)Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil. Electronic address: · Department of Public Health, Epidemiology and Biostatistics, University of Birmingham, Birmingham, UK. · (a)Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil. · Mood Disorders Psychopharmacology Unit, University of Toronto, Toronto, ON, Canada. · Memory Research Laboratory, Brain Institute (ICe), Federal University of Rio Grande do Norte (UFRN), Natal, RN, Brazil. · Laboratory of Neurosciences, Graduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, Criciúma, SC, Brazil; Center for Experimental Models in Psychiatry, Department of Psychiatry and Behavioral Sciences, The University of Texas Medical School at Houston, Houston, TX, USA. · Department of Psychiatry, University of Ioaninna, Ioaninna, Greece. · Mood Disorders Psychopharmacology Unit, University of Toronto, Toronto, ON, Canada; Departments of Psychiatry and Pharmacology, University of Toronto, Toronto, ON, Canada. · Bipolar Disorders Unit, Clinical Institute of Neurosciences, Hospital Clinic, IDIBAPS, University of Barcelona, CIBERSAM, Barcelona, Catalonia, Spain. · Pubmed 25451435
  • Department of Psychiatry, Medical University of Graz, Graz, Austria. · Department of Neurology, Medical University of Graz, Graz, Austria. · Department of Neurology, Medical University of Graz, Graz, Austria; Division of Neuroradiology, Department of Radiology, Medical University of Graz, Graz, Austria. · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Graz, Austria. · Division of Neuroradiology, Department of Radiology, Medical University of Graz, Graz, Austria. · Mood Disorders Psychopharmacology Unit at the University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26252714
  • Professor of Psychiatry and Pharmacology, Head, Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, Ontario, Canada. · Pubmed 26172636
  • Psychiatric Center Copenhagen, Department O and University of Copenhagen Denmark. Electronic address: · Department of Biostatistics University of Copenhagen Copenhagen, Denmark. · Department of Psychiatry and Pharmacology University of Toronto, Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ont., Canada. · Pubmed 25909752
  • University of Toronto, Departments of Psychiatry and Pharmacology, Mood Disorders Psychopharmacology Unit, 399 Bathurst St, MP 9-325, Toronto, ON, Canada M5T 2S8 · Pubmed 25844756
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Cleveland Clinic, Cleveland, OH, USA. · Medco Health Solutions, Inc, Fort Worth, TX, USA. · Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 25451425
  • Department of Psychiatry, Medical University of Graz, Graz, Austria. · Institute of Pathophysiology and Immunology, Medical University of Graz, Austria. · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Auenbruggerplatz 15, 8043 Graz, Austria. · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Auenbruggerplatz 15, 8043 Graz, Austria; BioTechMed-Graz, Austria. Electronic address: · Division of Biological Chemistry, Innsbruck Medical University, Innsbruck, Austria. · Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada; Department of Psychiatry and Pharmacology at the University of Toronto, Toronto, Canada. · Pubmed 25443762
2014
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 25090934
  • Department of Clinical Medicine and Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil. Electronic address: · Department of Psychiatry and Mood Disorders Psychopharmacology Unit, University of Toronto, Toronto, ON, Canada. · 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. · Department of Clinical and Theoretical Mental Health, Kutvolgyi Clinical Center, Semmelweis University, Budapest, Hungary; Department of Pharmacodynamics, Semmelweis University, Budapest, Hungary; Neuropsychopharmacology and Neurochemistry Research Group, National Academy of Sciences and Semmelweis University, Budapest, Hungary; National Institute of Psychiatry and Addictions, Laboratory for Suicide Research and Prevention, Budapest, Hungary. · IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, VIC, Australia; Department of Psychiatry, The Florey Institute of Neuroscience and Mental Health, and Orygen Youth Health Research Centre, University of Melbourne, Parkville, VIC, Australia. · Department of Clinical Medicine and Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil. · Department of Psychiatry, University of Ioaninna, Ioaninna, Greece. · Department of Psychiatry, Psychotherapy and Psychosomatics, Zurich University Hospital, Zurich, Switzerland. · Pubmed 24836088
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Department of Morphology and Genetics, Federal University of São Paulo, São Paulo, Brazil. · Institute of Biomedical Research and Faculty of Biosciences, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Pubmed 24548785
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Schulich School of Medicine and Dentistry, Western University, London, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 24468642
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 24330342
  • University of New Mexico, Health Sciences Center, Department of Psychiatry, Albuquerque, NM, USA. · University of Toronto, Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Kyushu University, Department of Neuropsychiatry, Fukuoka, Japan; East Asian Bipolar Forum, Fukuoka, Japan. · Eli Lilly Japan K.K., Lilly Research Laboratories, Statistical Science, Kobe, Japan. · Eli Lilly Japan K.K., Lilly Research Laboratories, Medical Science, Sannomiya Plaza Building, 7-1-5, Isogamidori, Chuo-ku, Kobe 651-0086, Japan. Electronic address: · Pubmed 25046739
  • University of New Mexico, Health Sciences Center, Department of Psychiatry, Albuquerque, NM, USA. · Kyushu University, Department of Neuropsychiatry, Fukuoka, Japan; East Asian Bipolar Forum, Fukuoka, Japan. · University of Toronto, Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Eli Lilly Japan K. K., Lilly Research Laboratories, Statistical Science, Kobe, Japan. · Eli Lilly Japan K. K., Lilly Research Laboratories, Medical Science, Kobe, Japan. Electronic address: · Pubmed 24856554
  • Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil; Department of Clinical Medicine, Faculty of Medicine, Fortaleza, Ceará, Brazil. Electronic address: · Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil. · Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil; Department of Clinical Medicine, Faculty of Medicine, Fortaleza, Ceará, Brazil. · Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil; Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, Ceará, Brazil. · 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. · Mood Disorders Unit (GRUDA), Department and Institute of Psychiatry, School of Medicine, University of Sao Paulo (IPq-HC-FMUSP), Brazil. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, School of Medicine, University of Ioannina, Ioannina, Greece. · Pubmed 24767016
2013
  • 1 Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · 3 Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Pubmed 24237641
  • Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada; Department of Psychiatry, University Health Network, Toronto, Canada. · Pubmed 24014142
2012
  • Mood Disorders Psychopharmacology Unit, University Health Network, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Pubmed 22563572
  • Mood Disorders Psychopharmacology Unit, University Health Network, Departments of Psychiatry and Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 22303523
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 22510034
  • Department of Psychiatry, University of Toronto, Toronto, Canada. · Pubmed 22182459
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 23107220
  • University of Toronto, Canada University Health Network, Canada. · Pubmed 22849038
2011
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 20950326
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; · Pubmed 21655345
  • Department of Psychiatry, University of Toronto, and Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Pubmed 21450149
  • Department of Psychiatry, University of Toronto, Ontario, Canada. · Pubmed 21382301
2010
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 20541810
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 20420486
  • Department of Psychiatry, University of Toronto, Canada. · Pubmed 20152551
  • Department of Psychiatry, University of Toronto, ON, Canada. · Pubmed 20878373
  • Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, ON, Canada. · Pubmed 20537396
  • University of Toronto, Toronto, ON, Canada M5T 2S8. · Pubmed 20096936
2018
  • University of Toronto, Toronto, Canada. · Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada. · Depression and Bipolar Support Alliance (DBSA), Chicago, Illinois. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Guangzhou Medical University, Guangzhou, China. · College of Medicine, Korea University, Seoul, Republic of Korea. · Pubmed 30412345
2016
  • aDepartment of Psychiatry, Dalhousie University, Halifax, CanadabNational Institute of Mental Health, Klecany, Czech RepubliccDepartment of Psychiatry, University of Toronto, Toronto, Canada. · Pubmed 26575297
2014
  • Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil (Dr Carvalho); Center for Experimental Models in Psychiatry, Department of Psychiatry and Behavioral Sciences, The University of Texas Medical School at Houston, Houston, TX (Dr Quevedo); Laboratory of Neurosciences, Graduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, Criciúma, SC, Brazil (Dr Quevedo); Departments of Psychiatry and Pharmacology and Mood Disorders Psychopharmacology Unit, University of Toronto, Toronto, ON, Canada (Dr McIntyre); Mood Disorders Unit (GRUDA), Department and Institute of Psychiatry, School of Medicine, University of São Paulo (IPq-FMUSP), São Paulo, Brazil (Dr Souza); 3rd Department of Psychiatry, Aristotle University of Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Victoria, Australia (Dr Berk); Department of Psychiatry, the Florey Institute of Neuroscience and Mental Health, and Orygen Youth Health Research Centre, University of Melbourne, Parkville, Australia (Dr Berk); Department of Psychiatry, Medical School, University of Ioaninna, Ioaninna, Greece (Dr Hyphantis); Bipolar Disorders Unit, Clinical Institute of Neurosciences, Hospital Clinic, IDIBAPS, University of Barcelona, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta) · Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil (Dr Carvalho); Center for Experimental Models in Psychiatry, Department of Psychiatry and Behavioral Sciences, The University of Texas Medical School at Houston, Houston, TX (Dr Quevedo); Laboratory of Neurosciences, Graduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, Criciúma, SC, Brazil (Dr Quevedo); Departments of Psychiatry and Pharmacology and Mood Disorders Psychopharmacology Unit, University of Toronto, Toronto, ON, Canada (Dr McIntyre); Mood Disorders Unit (GRUDA), Department and Institute of Psychiatry, School of Medicine, University of São Paulo (IPq-FMUSP), São Paulo, Brazil (Dr Souza); 3rd Department of Psychiatry, Aristotle University of Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Victoria, Australia (Dr Berk); Department of Psychiatry, the Florey Institute of Neuroscience and Mental Health, and Orygen Youth Health Research Centre, University of Melbourne, Parkville, Australia (Dr Berk); Department of Psychiatry, Medical School, University of Ioaninna, Ioaninna, Greece (Dr Hyphantis); Bipolar Disorders Unit, Clinical Institute of Neurosciences, Hospital Clinic, IDIBAPS, University of Barcelona, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta). · Pubmed 25522415
2013
  • Department of Human Biology, University of Toronto, Toronto, ON, Canada. · Pubmed 24194362
2012
  • Mood and Anxiety Disorders Program, Sunnybrook Health Sciences Centre, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Pubmed 22303519
2010
  • Division of Neurosurgery, University Health Network Department of Psychiatry, University of Toronto, University Health Network, 399 Bathurst Street, Toronto, Ontario, Canada. · Pubmed 21040286
  • University of Toronto, Ontario, Canada. · Pubmed 20840804
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 157 total) written by Roger S. McIntyre about Bipolar Disorder:

  • Inflammation, brain structure and cognition interrelations among individuals with differential risks for bipolar disorder. 2020
  • Affective cognition in bipolar disorder: A systematic review by the ISBD targeting cognition task force. 2019
  • Machine learning and big data analytics in bipolar disorder: A position paper from the International Society for Bipolar Disorders Big Data Task Force. 2019
  • Association between diabetes and mood disorders and the potential use of anti-hyperglycemic agents as antidepressants. 2019
  • A clinical model for identifying an inflammatory phenotype in mood disorders. 2019
  • Advances and challenges in development of precision psychiatry through clinical metabolomics on mood and psychotic disorders. 2019
  • Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study. 2019
  • Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies. 2019
  • Parsing metabolic heterogeneity in mood disorders: A hypothesis-driven cluster analysis of glucose and insulin abnormalities. 2019
  • Cariprazine for the treatment of bipolar mania with mixed features: A post hoc pooled analysis of 3 trials. 2019
Show List of Full Article Records
Google Searches

Learn more about Roger S. McIntyre using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University Health Network of Toronto
Guangzhou Medical University
University of Toronto
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University Health Network of Toronto
2020
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China; Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China; Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, China; Laboratory of Neuropsychology and Laboratory of Social Cognitive Affective Neuroscience, Department of Psychology, University of Hong Kong, Hong Kong. Electronic address: · Laboratory of Neuropsychology and Laboratory of Social Cognitive Affective Neuroscience, Department of Psychology, University of Hong Kong, Hong Kong. Electronic address: · Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China; Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China. · Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Department of Radiology, The Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, Queen's University, School of Medicine, Kingston, ON, Canada. · Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, China. · Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hung Hom, Hong Kong. · Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China. · Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China; Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, China; The State Key Laboratory of Brain and Cognitive Sciences and Department of Ophthalmology, University of Hong Kong, Hong Kong. Electronic address: · Pubmed 31614176
2019
  • Post-Graduation Program in Psychiatry and Medical Psychology, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil; Research Group in Molecular and Behavioral Neuroscience of Mood Disorders, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil. · Post-Graduation Program in Psychiatry and Medical Psychology, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil; Research Group in Molecular and Behavioral Neuroscience of Mood Disorders, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil; Department of Psychiatry, Queen's University School of Medicine, Kingston, ON, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, Queen's University School of Medicine, Kingston, ON, Canada. · Department of Internal Medicine, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil; Unit of Endocrinology and Metabolism, Hospital de Clinicas de Porto Alegre, Porto Alegre, RS, Brazil. · Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; Department of Psychiatry and Centre for Neuroscience Studies, Queen's University, Kingston, ON, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada; Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Pubmed 31352032
  • Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, Canada; Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China. · Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo, São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, Canada. · Department of Organic Chemitry, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo, São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, Canada. Electronic address: · Pubmed 30904564
  • Allergan, Madison, N.J. (Earley, Burgess, Rekeda, Dickinson) · Gedeon Richter, Budapest, Hungary (Szatmári, Németh) · the Mood Disorders Psychopharmacology Unit, University Health Network, Toronto (McIntyre) · the Department of Psychiatry, Harvard Medical School, and the Bipolar Clinic and Research Program, Massachusetts General Hospital, Boston (Sachs) · and the Department of Psychiatry, University of British Columbia, Vancouver (Yatham). · Pubmed 30845817
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA. · Bipolar and Depression Research Program, VA Palo Alto Health Care System, Palo Alto, California, USA. · Clinical Development, Allergan, Madison, New Jersey, USA. · Medical Affairs, Allergan, Madison, New Jersey, USA. · Department of Psychiatry, University of California, San Diego, California, USA. · Pubmed 31576791
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Department of Psychiatry, University of Toronto, Toronto, Canada. · Department of Psychiatry, Queen's University, Kingston, Canada. · Department of Psychiatry, Research Group in Molecular and Behavioral Neurosciences of Mood Disorders, Universidade Federal de São Paulo, Sao Paulo, Brazil. · Brain and Cognition Discovery Foundation, Toronto, Canada. · Pubmed 31464359
  • Mood Disorders Psychopharmacology Unit, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada; Brain Cognition Discovery Foundation, Toronto, Ontario, Canada. Electronic address: · Centers of Psychiatric Excellence, New York, New York, United States. · Allergan plc, Madison, NJ, United States. · Pubmed 31344528
  • Mood Disorders Psychopharmacology Unit, University Health Network , Toronto , Canada. · University Hospitals Cleveland Medical Center , Cleveland , OH , USA. · Pubmed 31311335
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Laboratory of Neuropsychology, Laboratory of Social Cognitive Affective Neuroscience, Department of Psychology, The University of Hong Kong, Hong Kong, China. · Department of Psychology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), Guangzhou, China. · Academician workstation of Mood and Brain Sciences, Guangzhou Medical University, Guangzhou, China. · Laboratory of Emotion and Cognition, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Department of Psychology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. · GMH Institute of CNS Regeneration, Jinan University, Guangzhou, China. · The State Key Laboratory of Brain and Cognitive Sciences and Department of Ophthalmology, University of Hong Kong, Hong Kong, China. · Pubmed 31282606
  • a Department of Psychiatry and Pharmacology , University of Toronto , Toronto , Canada. · b Mood Disorders Psychopharmacology Unit, University Health Network , Toronto , Canada. · c Brain and Cognition Discovery Foundation , Toronto , Canada. · d Department of Psychiatry and Gastroenterology, McMaster University , Hamilton , Canada. · Pubmed 31132957
  • Copenhagen Affective Disorders Research Centre (CADIC), Psychiatric Center Copenhagen, Department O, 6243, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. · Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Copenhagen Affective Disorders Research Centre (CADIC), Psychiatric Center Copenhagen, Department O, 6243, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. · Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Clinical Metabolic Physiology, Steno Diabetes Center Copenhagen, Gentofte Hospital, Hellerup, Denmark. · Centre of Inflammation and Metabolism (CIM) and the Centre for Physical Activity Research (CFAS), Rigshospitalet, Copenhagen, Denmark. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Pubmed 30937579
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30795495
  • a Mood Disorders Psychopharmacology Unit , University Health Network , Toronto , Canada. · b Department of Psychiatry , University of Toronto , Toronto , Canada. · c Department of Pharmacology , University of Toronto , Toronto , Canada. · Pubmed 30753085
  • Department of Psychiatry, Federal University of São Paulo, SP, Brazil. · Department of Psychiatry, University of Toronto, ON, Canada; Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Brain and Cognition Discovery Foundation, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Federal University of São Paulo, SP, Brazil; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Pubmed 30611064
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: · Department of Psychiatry, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, United States. · Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Boston, MA, United States. · Neurocrine Biosciences, Inc., San Diego, CA, United States. · Pubmed 30583148
  • 1 The Copenhagen Affective Disorder Research Center (CADIC), Psychiatric Center Copenhagen, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. · 2 Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Pubmed 30518229
  • Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua 3 de maio 100, Ed. INFAR, 3rd floor, CEP 04044-020 São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua Pedro de Toledo, 669, 3rd floor, Vila Clementino, CEP 04039-032 São Paulo, Brazil. Electronic address: · Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua 3 de maio 100, Ed. INFAR, 3rd floor, CEP 04044-020 São Paulo, Brazil. Electronic address: · Pubmed 30321766
  • Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada. · Depression and Bipolar Support Alliance (DBSA), Chicago, IL, United States; Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States. · Depression and Bipolar Support Alliance (DBSA), Chicago, IL, United States. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada; Depression and Bipolar Support Alliance (DBSA), Chicago, IL, United States. Electronic address: · Pubmed 30241026
2018
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada. · Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychological Medicine, National University of Singapore, Singapore. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada Institute of Medical Science, University of Toronto, Toronto, ON, Canada Department of Psychiatry, University of Toronto, Toronto, ON, Canada Department of Pharmacology, University of Toronto, Toronto, ON, Canada. · Pubmed 30524702
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada; Department of Psychiatry, Federal University of São Paulo (Unifesp), São Paulo, Brazil. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. · Unitat Docent de Psiquiatria i Psicologia Mèdica, Departament de Medicina, Universitat de València, Valencia Unitat de Salut Mental de Catarroja, Valencia Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto Carlos III, Madrid International Society for Nutritional Psychiatry Research (ISNPR), Spain. · Psychiatric Centre Copenhagen, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. · Hospital Universitario de Alava-Santiago, CIBERSAM, EHU, Vitoria, Spain. · Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Department of Psychological Medicine, National University Health System, Singapore, Singapore. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada. · Pubmed 30075165
  • UHN-Toronto Western Hospital, Mood Disorders Psychopharmacology Unit, University of Toronto, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. · Department of Psychological Medicine, King's College London and South London and Maudsley NHS Foundation Trust, London, UK. · Neuroscience and Psychiatry Unit, University of Manchester, Manchester, UK. · Pubmed 29977518
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, Federal University of São Paulo, São Paulo 05403-903, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Department of Pharmacology, University of Toronto, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. · Pubmed 29673146
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Institute of Medical Science, University of Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. · Pubmed 29481915
  • Mood Disorder Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 29102836
  • Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil; Mood Disorders Psychpharmachology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), University of Toronto, Toronto, Canada. Electronic address: · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Mood Disorders Psychpharmachology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Pubmed 28830676
  • Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada. · Depression and Bipolar Support Alliance, Chicago, Illinois, USA. · Kaiser Permanente Washington Health Research Insitute, Seattle, Washington, USA. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, 399 Bathurst St, MP 9-325, Toronto, ON M5T 2S8, Canada. · Pubmed 30444959
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. Electronic address: · Department of Psychiatry and Behavioral Sciences, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, USA. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA. · Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; Centre for Neuroscience Studies, Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada. · Center for Neuroscience in Women's Health, Stanford University, Palo Alto, USA. · Laboratory of Neuroendocrinology, The Rockefeller University, New York, USA. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo, SP, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. · Pubmed 30391805
  • Mood Disorders Psychopharmacology Unit, University Health Network,Toronto, ON M5T 2S8 Canada;E-mail: · Pubmed 30372507
  • Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil. · Laboratory of Emotion and Cognition, Department of Affective Disorders, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China; Department of Neuropsychology, University of Hong Kong, Hong Kong, China. · School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Psychiatry, Chang Gung Memorial Hospital, Chiayi, Taiwan. · Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. · Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30153635
  • Johns Hopkins University and the Kennedy Krieger Institute, Baltimore, MD, USA, · Allergan, Madison, NJ, USA. · VA Palo Alto Health Care System, Palo Alto, CA, USA. · Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. · Toronto Western Research Institute, Toronto, ON, Canada. · Pubmed 30122926
  • Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK. · Centre for Affective Disorders, IoPPN, Kings College, London, UK. · Psychiatry Department, Santa Casa School of Medical Sciences, São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, Toronto, Ontario, Canada. · Pubmed 29888230
  • Medical University of Graz, Department of Psychiatry and Psychotherapeutic Medicine, Graz, Austria. · Medical University of Graz, Department of Psychiatry and Psychotherapeutic Medicine, Graz, Austria. Electronic address: · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Graz, Austria. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 29433074
  • Dent Neurologic Institute, Amherst, NY, USA. · University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, USA. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 29427512
  • Research Group of Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil; Post-Graduation Program in Psychiatry and Medical Psychology, Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), Toronto, ON, Canada. · Developmental Cognitive Neuroscience Laboratory (DCNL), Brain Institute (InsCer), Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil. · Santa Casa School of Medical Sciences of São Paulo, São Paulo, Brazil. · Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), Toronto, ON, Canada; Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Research Group of Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil; Post-Graduation Program in Psychiatry and Medical Psychology, Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), Toronto, ON, Canada. Electronic address: · Pubmed 29102835
  • Department of Psychiatry, Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital at Chiayi, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan. · School of Medicine, Chang Gung University, Taoyuan, Taiwan; Health Information and Epidemiology Laboratory, Chang Gung Memorial Hospital, Chiayi, Taiwan; Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University, College of Public Health, Taipei, Taiwan. · Health Information and Epidemiology Laboratory, Chang Gung Memorial Hospital, Chiayi, Taiwan. · University of California, San Francisco (UCSF), USA. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Canada; Department of Psychiatry, University of Toronto, Canada. · Department of Speech, Language Pathology and Audiology, Chung Shan Medical University, Taiwan. · Department of Medicine, Mackay Medical College, Taipei, Taiwan; Department of Psychiatry, Mackay Memorial Hospital, Taipei, Taiwan; Department of Audiology, Speech, and Language Pathology, Mackay Medical College, Taipei, Taiwan. Electronic address: · Pubmed 28972929
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28944976
  • Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada. · Grupo de Pesquisa em Neurociência Comportamental e Molecular do Transtorno Bipolar, Departamento de Psiquiatria, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Pubmed 30156658
2017
  • Department of Psychiatry, University of Toronto, Toronto, ON M5T 2S8, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 2S8, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada. · Pubmed 29084144
  • a Department of Psychiatry , University of Toronto , Toronto , Canada. · b Mood Disorders Psychopharmacology Unit , University Health Network , Toronto , Canada. · c Brain and Cognition Discovery Foundation , Toronto , Canada. · d Neuralstem , 20271 Goldenrod Lane, Germantown , MD 20876 , USA. · Pubmed 28460574
  • 1Department of Psychiatry,University of California,San Diego,California,USA. · 3Neuroscience Education Institute,Carlsbad,California,USA. · 4Lucio Bini Mood Disorders Center,New York,New York,USA. · 5Department of Psychiatry,Massachusetts General Hospital,Boston,Massachusetts,USA. · 6Department of Psychiatry,Icahn School of Medicine at Mount Sinai,New York,New York,USA. · 7Research Institute at the Lindner Center of HOPE,Mason,Ohio,USA. · 8Mood Disorders Psychopharmacology Unit,University Health Network,Toronto,Ontario,Canada. · 10Department of Psychiatry,University of Sydney,Sydney,Australia. · 11Centro Lucio Bini,Rome,Italy. · 12VA Palo Alto Health Care System,Palo Alto,California,USA. · 14Hospital Clinic,Institute of Neuroscience,University of Barcelona,IDIBAPS,CIBERSAM,Barcelona,Catalonia,Spain. · 15Psychiatry Clinic,Sainen,Kanazawa City,Ishikawa Prefecture,Japan. · 16Department of Psychiatry,Perelman School of Medicine,University of Pennsylvania, and the Corporal Michael J. Crescenz Veterans Affairs Medical Center,Philadelphia,Pennsylvania,USA. · 17Department of Psychological Medicine,Kings College,London,United Kingdom. · 18Department of Psychiatry,Rhode Island Hospital,Providence,Rhode Island,USA. · Pubmed 28421980
  • University of São Paulo (USP), São Paulo, Brazil; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. Electronic address: · Pubmed 28107669
  • Mood Disorder Psychopharmacology Unit,University Health Network,Department of Psychiatry,University of Toronto,Toronto,Ontario,Canada. · Pubmed 27618746
  • VA Palo Alto Health Care System and Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. · H. Lundbeck A/S, Valby, Copenhagen, Denmark. · Department of Clinical Sciences, Lund University, Lund, Sweden. · Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London, London, UK. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, ON, Canada. · Pubmed 29105003
  • Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, Kuwait University, Kuwait City, Kuwait. · Psychosocial Oncology Clinic, University Health Network, Toronto, ON, Canada. · Department of Psychology, University of Toronto, Toronto, ON, Canada. · Neuropsychology Clinic, University Health Network, Toronto, ON, Canada. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Department of Psychiatry, Women's College Hospital, Toronto, ON, Canada. · Department of Toxicology and Pharmacology, University of Toronto, Toronto, ON, Canada. · Pubmed 28599348
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology, University of Toronto, Ontario, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Laboratory of Emotion and Cognition, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28493605
  • Department of Psychiatry and Psychotherapy, Medical University of Graz, Graz, Austria. · Department of Psychiatry and Psychotherapy, Medical University of Graz, Graz, Austria. Electronic address: · Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria. · Division of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria. · Institute of Laboratory Medicine, Medical Center of Munich University (LMU), Munich, Germany. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 28482311
  • Department of Psychiatry, Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital at Chiayi, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Nursing, Chang Gung Institute of Technology, Taoyuan, Taiwan. · Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital at Chiayi, Taiwan. · School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Neurosurgery, Chang Gung Memorial Hospital at Chiayi, Taiwan. · Center of Excellence for Chang Gung Research Datalink, Chang Gung Memorial Hospital at Chiayi, Taiwan. · Center of Excellence for Chang Gung Research Datalink, Chang Gung Memorial Hospital at Chiayi, Taiwan; Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital, at Chiayi, Taiwan; Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University College of Public Health, Taipei, Taiwan. · Department of Psychiatry, Wan-Fang Hospital & School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. · Department of Neurology, Kaohsiung Medical University and Hospital, Kaohsiung, Taiwan. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Department of Psychiatry, Chung Shan Medical University Hospital, Taichung, Taiwan; Department of Psychiatry, School of Medicine, Chung Shan Medical University, Taichung, Taiwan. · Department of Psychiatry, Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital at Chiayi, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan. Electronic address: · Pubmed 28477503
  • Reserach Group in Behavioral and Molecular Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 28457001
  • Mood Disorders Psychopharmacology Unit,University Health Network,Toronto,Ontario,Canada. · Pubmed 28264727
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Division of Endocrinology, Mount Sinai Hospital, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Research Division, Institute of Mental Health, Singapore. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Department of Psychiatry, Stanford University, Palo Alto, CA, United States. · Department of Psychiatry, Dalhousie University, Halifax, Canada. · Pubmed 27721184
  • Mood Disorder Psychopharmacology Unit,University Health Network,Department of Psychiatry,University of Toronto,Toronto,Ontario,Canada. · Pubmed 27629159
2016
  • Departments of Psychiatry and Pharmacology, Mood Disorders Psychopharmacology Unit, University of Toronto, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada. · Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceará, Rua Prof. Costa Mendes, 1608, 4o andar, 60.430-140 Fortaleza, CE, Brazil. · Pubmed 26812953
  • 1Mood Disorders Psychopharmacology Unit,University Health Network,Toronto,Ontario,Canada. · Pubmed 28044944
  • Resident of Psychiatry, Clinician Scientist Stream, University of Toronto, Toronto, ON, Canada. · Resident of Psychiatry, Western University, London, ON, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Canada; Psychiatry and Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 27400335
  • Mood Disorders Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada. · Department of Psychiatry, Western University, London and Windsor, ON, Canada. · IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Vic., Australia. · Department of Psychiatry, The Florey Institute of Neuroscience and Mental Health, and Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, University of Melbourne, Parkville, Vic., Australia. · Psychiatric Center Copenhagen, Faculty of Health and Medical Sciences and Department O, University of Copenhagen, Copenhagen, Denmark. · Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, São Paulo, Brazil. · Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Departments of Psychiatry, Pharmacology, and Psychological Clinical Science, Centre for Youth Bipolar Disorder, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. · Pubmed 26990051
  • Mood Disorder Psychopharmacology Unit, University Health Network, University of Toronto, 399 Bathurst Street, MP 9-325, Toronto, Ontario M5T 2S8, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, University of Toronto, 399 Bathurst Street, MP 9-325, Toronto, Ontario M5T 2S8, Canada. Electronic address: · Pubmed 26876323
  • Research Division, Institute of Mental Health, Singapore, 10 Buangkok View, Singapore 539747, Singapore. · Department of General Psychiatry, Institute of Mental Health/Woodbridge Hospital, Singapore, 10 Buangkok View, Singapore 539747, Singapore. · Division of Psychiatry, Department of Molecular Medicine, University at Siena, Italy, Viale Bracci 1, 53100 Siena, Italy. · Mood Disorders Psychopharmacology Unit, University of Toronto, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada. · Bipolar Disorders Program, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain. · Research Division, Institute of Mental Health, Singapore, 10 Buangkok View, Singapore 539747, Singapore; Department of General Psychiatry, Institute of Mental Health/Woodbridge Hospital, Singapore, 10 Buangkok View, Singapore 539747, Singapore. Electronic address: · Pubmed 26691725
  • Merck, Whitehouse Station, NJ, USA. · Forest Research Institute (now Actavis), Jersey City, NJ, USA. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, ON, Canada. · Forest Research Institute (now Actavis), Jersey City, NJ, USA. Electronic address: · Pubmed 26496015
  • Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 27488494
  • Faculty of Kinesiology and Physical Education, University of Toronto, 55 Harbord Street, Toronto, ON, M5S2W6, Canada. · School of Kinesiology, University of British Columbia, 2146 Health Sciences Mall, Room 4606, Vancouver, BC, V6T 1Z3, Canada. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON, M5T 2S8, Canada. · Schizophrenia Program Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada. · School of Kinesiology, University of British Columbia, 2146 Health Sciences Mall, Room 4606, Vancouver, BC, V6T 1Z3, Canada. · Pubmed 27405745
  • Department of Psychiatry, Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Bipolar Disorder Program and Laboratory of Molecular Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · Pubmed 27324989
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 27281261
  • Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Centre for Research in Occupational Safety and Health, Laurentian University, Sudbury, Ontario, Canada. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; University Health Network in Toronto, Ontario, Canada. · University of Calgary in Calgary, Alberta, Canada. · Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · University of British Columbia, Vancouver, British Columbia, Canada. · Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 27182964
  • Department of Psychiatry, Medical University of Graz, Graz, Austria. · Department of Psychology, Karl-Franzens University of Graz, Graz, Austria. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria. · Division of Biological Chemistry, Innsbruck Medical University, Innsbruck, Austria. · Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich, Germany. · Pubmed 27016286
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26866976
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26748249
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Cleveland Clinic, Cleveland, OH, USA. · Turn2Health Solutions, Willoughby, OH, USA. · Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil. · Department of Neuropsychiatry, University of South Carolina School of Medicine, USA. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26508286
2015
  • Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26363613
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 25579847
  • Department of Psychiatry, Medical University of Graz, Graz, Austria. · Department of Neurology, Medical University of Graz, Graz, Austria. · Department of Neurology, Medical University of Graz, Graz, Austria; Division of Neuroradiology, Department of Radiology, Medical University of Graz, Graz, Austria. · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Graz, Austria. · Division of Neuroradiology, Department of Radiology, Medical University of Graz, Graz, Austria. · Mood Disorders Psychopharmacology Unit at the University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26252714
  • Professor of Psychiatry and Pharmacology, Head, Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, Ontario, Canada. · Pubmed 26172636
  • Psychiatric Center Copenhagen, Department O and University of Copenhagen Denmark. Electronic address: · Department of Biostatistics University of Copenhagen Copenhagen, Denmark. · Department of Psychiatry and Pharmacology University of Toronto, Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ont., Canada. · Pubmed 25909752
  • University of Toronto, Departments of Psychiatry and Pharmacology, Mood Disorders Psychopharmacology Unit, 399 Bathurst St, MP 9-325, Toronto, ON, Canada M5T 2S8 · Pubmed 25844756
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Cleveland Clinic, Cleveland, OH, USA. · Medco Health Solutions, Inc, Fort Worth, TX, USA. · Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 25451425
  • Department of Psychiatry, Medical University of Graz, Graz, Austria. · Institute of Pathophysiology and Immunology, Medical University of Graz, Austria. · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Auenbruggerplatz 15, 8043 Graz, Austria. · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Auenbruggerplatz 15, 8043 Graz, Austria; BioTechMed-Graz, Austria. Electronic address: · Division of Biological Chemistry, Innsbruck Medical University, Innsbruck, Austria. · Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada; Department of Psychiatry and Pharmacology at the University of Toronto, Toronto, Canada. · Pubmed 25443762
2014
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 25090934
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Department of Morphology and Genetics, Federal University of São Paulo, São Paulo, Brazil. · Institute of Biomedical Research and Faculty of Biosciences, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Pubmed 24548785
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Schulich School of Medicine and Dentistry, Western University, London, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 24468642
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 24330342
  • University of New Mexico, Health Sciences Center, Department of Psychiatry, Albuquerque, NM, USA. · University of Toronto, Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Kyushu University, Department of Neuropsychiatry, Fukuoka, Japan; East Asian Bipolar Forum, Fukuoka, Japan. · Eli Lilly Japan K.K., Lilly Research Laboratories, Statistical Science, Kobe, Japan. · Eli Lilly Japan K.K., Lilly Research Laboratories, Medical Science, Sannomiya Plaza Building, 7-1-5, Isogamidori, Chuo-ku, Kobe 651-0086, Japan. Electronic address: · Pubmed 25046739
  • University of New Mexico, Health Sciences Center, Department of Psychiatry, Albuquerque, NM, USA. · Kyushu University, Department of Neuropsychiatry, Fukuoka, Japan; East Asian Bipolar Forum, Fukuoka, Japan. · University of Toronto, Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Eli Lilly Japan K. K., Lilly Research Laboratories, Statistical Science, Kobe, Japan. · Eli Lilly Japan K. K., Lilly Research Laboratories, Medical Science, Kobe, Japan. Electronic address: · Pubmed 24856554
  • Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil; Department of Clinical Medicine, Faculty of Medicine, Fortaleza, Ceará, Brazil. Electronic address: · Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil. · Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil; Department of Clinical Medicine, Faculty of Medicine, Fortaleza, Ceará, Brazil. · Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil; Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, Ceará, Brazil. · 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. · Mood Disorders Unit (GRUDA), Department and Institute of Psychiatry, School of Medicine, University of Sao Paulo (IPq-HC-FMUSP), Brazil. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, School of Medicine, University of Ioannina, Ioannina, Greece. · Pubmed 24767016
2013
  • Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada; Department of Psychiatry, University Health Network, Toronto, Canada. · Pubmed 24014142
2012
  • Mood Disorders Psychopharmacology Unit, University Health Network, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Pubmed 22563572
  • Mood Disorders Psychopharmacology Unit, University Health Network, Departments of Psychiatry and Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 22303523
  • University Health Network, Mood Disorders Psychopharmacology Unit, 399 Bathurst Street, Toronto, Ontario, M5T 2S8, Canada. · Pubmed 22559286
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 22510034
  • Department of Psychiatry, University of Toronto, Toronto, Canada. · Pubmed 22182459
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 23107220
  • University of Toronto, Canada University Health Network, Canada. · Pubmed 22849038
2011
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 20950326
  • Department of Psychiatry, University of Toronto, and Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Pubmed 21450149
2010
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 20541810
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 20420486
  • Department of Psychiatry, University of Toronto, Canada. · Pubmed 20152551
  • Department of Psychiatry, University of Toronto, ON, Canada. · Pubmed 20878373
  • Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, ON, Canada. · Pubmed 20537396
  • University of Toronto, Toronto, ON, Canada M5T 2S8. · Pubmed 20096936
2018
  • University of Toronto, Toronto, Canada. · Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada. · Depression and Bipolar Support Alliance (DBSA), Chicago, Illinois. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Guangzhou Medical University, Guangzhou, China. · College of Medicine, Korea University, Seoul, Republic of Korea. · Pubmed 30412345
2014
  • Centre for Neuroscience Studies, Queen's University, Kingston, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Pubmed 24467470
2013
  • Mood Disorders Psychopharmacology Unit, University Health Network, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. · Pubmed 23839119
2010
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Pubmed 21084787
  • Division of Neurosurgery, University Health Network Department of Psychiatry, University of Toronto, University Health Network, 399 Bathurst Street, Toronto, Ontario, Canada. · Pubmed 21040286
  • University of Toronto, Ontario, Canada. · Pubmed 20840804
Guangzhou Medical University
2020
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China; Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China; Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, China; Laboratory of Neuropsychology and Laboratory of Social Cognitive Affective Neuroscience, Department of Psychology, University of Hong Kong, Hong Kong. Electronic address: · Laboratory of Neuropsychology and Laboratory of Social Cognitive Affective Neuroscience, Department of Psychology, University of Hong Kong, Hong Kong. Electronic address: · Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China; Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China. · Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Department of Radiology, The Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, Queen's University, School of Medicine, Kingston, ON, Canada. · Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, China. · Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hung Hom, Hong Kong. · Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China. · Academician Workstation of Mood and Brain Sciences, Guangzhou Medical University, China; Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, China; The State Key Laboratory of Brain and Cognitive Sciences and Department of Ophthalmology, University of Hong Kong, Hong Kong. Electronic address: · Pubmed 31614176
2019
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Laboratory of Neuropsychology, Laboratory of Social Cognitive Affective Neuroscience, Department of Psychology, The University of Hong Kong, Hong Kong, China. · Department of Psychology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), Guangzhou, China. · Academician workstation of Mood and Brain Sciences, Guangzhou Medical University, Guangzhou, China. · Laboratory of Emotion and Cognition, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Department of Psychology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. · GMH Institute of CNS Regeneration, Jinan University, Guangzhou, China. · The State Key Laboratory of Brain and Cognitive Sciences and Department of Ophthalmology, University of Hong Kong, Hong Kong, China. · Pubmed 31282606
2018
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28944976
2017
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology, University of Toronto, Ontario, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Laboratory of Emotion and Cognition, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28493605
2018
  • University of Toronto, Toronto, Canada. · Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada. · Depression and Bipolar Support Alliance (DBSA), Chicago, Illinois. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Guangzhou Medical University, Guangzhou, China. · College of Medicine, Korea University, Seoul, Republic of Korea. · Pubmed 30412345
University of Toronto
2019
  • Copenhagen Affective Disorder Research Centre (CADIC), Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Department of Psychology, University of Copenhagen, Copenhagen, Denmark. · Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA. · Department of Psychiatry, Harvard Medical School, Boston, MA, USA. · Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain. · Department of Psychology, Queen's University, Kingston, Canada. · Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, Canada. · Institute of Neuroscience, Newcastle University, Newcastle-upon-Tyne, UK. · Psychiatry Research Unit, University of Fribourg, Fribourg, Switzerland. · Bipolar Disorder Research Program, Departamento de Psiquiatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, Brazil. · Research Group in Psychiatry, Department of Psychiatry, Universidad de Antioquia, Medellín, Colombia. · Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan. · Mood Disorders Psychopharmacology Unit Brain and Cognition Discovery Foundation, University of Toronto, Toronto, Canada. · Department of Psychological Medicine, University of Otago, Christchurch, New Zealand. · Department of Psychiatry, University of Alberta, Edmonton, Canada. · Department of Psychiatry, University of British Columbia, Vancouver, Canada. · Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. · Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne, Carlton, Australia. · Centre for Mental Health, Faculty of Health, Arts and Design, Swinburne University, Australia. · Pubmed 31491048
  • Laboratory of Molecular Psychiatry and Bipolar Disorder Program, Programa de Pós-Graduação em Psiquiatria e Ciências do Comportamento, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · School of Technology, Pontifícia Universidade Católica do Rio Grande do Sul, Rio Grande do Sul, Brazil. · Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada. · Department of Psychiatry and Behavioral Sciences, UT Center of Excellence on Mood Disorders, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA. · Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Department of Psychiatry, Queen's University School of Medicine, Kingston, ON, Canada. · Department of Psychiatry, Dalhousie University, Halifax, NS, Canada. · National Institute of Mental Health, Klecany, Czech Republic. · Research Group in Psychiatry, Department of Psychiatry, Faculty of Medicine, University of Antioquia, Medellín, Colombia. · Mood Disorders Program, Hospital Universitario San Vicente Fundación, Medellín, Colombia. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. · Department of Psychiatry, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. · Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Copenhagen Affective Disorder Research Center (CADIC), Psychiatric Center Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark. · Pubmed 31465619
  • Post-Graduation Program in Psychiatry and Medical Psychology, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil; Research Group in Molecular and Behavioral Neuroscience of Mood Disorders, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil. · Post-Graduation Program in Psychiatry and Medical Psychology, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil; Research Group in Molecular and Behavioral Neuroscience of Mood Disorders, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil; Department of Psychiatry, Queen's University School of Medicine, Kingston, ON, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, Queen's University School of Medicine, Kingston, ON, Canada. · Department of Internal Medicine, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil; Unit of Endocrinology and Metabolism, Hospital de Clinicas de Porto Alegre, Porto Alegre, RS, Brazil. · Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; Department of Psychiatry and Centre for Neuroscience Studies, Queen's University, Kingston, ON, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada; Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Pubmed 31352032
  • Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: · Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. · University of Toronto, Toronto, Canada. · University of Toronto, Toronto, Canada; MDPU, BCDF, UHN, Toronto, Ontario, USA. · Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA; VA Palo Alto Health Care System, Palo Alto, CA, USA. · Pubmed 30954775
  • Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, Canada; Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China. · Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo, São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, Canada. · Department of Organic Chemitry, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo, São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, Canada. Electronic address: · Pubmed 30904564
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Department of Psychiatry, University of Toronto, Toronto, Canada. · Department of Psychiatry, Queen's University, Kingston, Canada. · Department of Psychiatry, Research Group in Molecular and Behavioral Neurosciences of Mood Disorders, Universidade Federal de São Paulo, Sao Paulo, Brazil. · Brain and Cognition Discovery Foundation, Toronto, Canada. · Pubmed 31464359
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Laboratory of Neuropsychology, Laboratory of Social Cognitive Affective Neuroscience, Department of Psychology, The University of Hong Kong, Hong Kong, China. · Department of Psychology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), Guangzhou, China. · Academician workstation of Mood and Brain Sciences, Guangzhou Medical University, Guangzhou, China. · Laboratory of Emotion and Cognition, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Department of Psychology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. · GMH Institute of CNS Regeneration, Jinan University, Guangzhou, China. · The State Key Laboratory of Brain and Cognitive Sciences and Department of Ophthalmology, University of Hong Kong, Hong Kong, China. · Pubmed 31282606
  • a Department of Psychiatry and Pharmacology , University of Toronto , Toronto , Canada. · b Mood Disorders Psychopharmacology Unit, University Health Network , Toronto , Canada. · c Brain and Cognition Discovery Foundation , Toronto , Canada. · d Department of Psychiatry and Gastroenterology, McMaster University , Hamilton , Canada. · Pubmed 31132957
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30795495
  • a Mood Disorders Psychopharmacology Unit , University Health Network , Toronto , Canada. · b Department of Psychiatry , University of Toronto , Toronto , Canada. · c Department of Pharmacology , University of Toronto , Toronto , Canada. · Pubmed 30753085
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: · Department of Psychiatry, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, United States. · Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Boston, MA, United States. · Neurocrine Biosciences, Inc., San Diego, CA, United States. · Pubmed 30583148
  • Department of Psychiatry,Dokuz Eylul University School of Medicine,Izmir,Turkey. · Department of Psychiatry,University of Toronto,Toronto, ON,Canada. · Pubmed 30326979
  • Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua 3 de maio 100, Ed. INFAR, 3rd floor, CEP 04044-020 São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua Pedro de Toledo, 669, 3rd floor, Vila Clementino, CEP 04039-032 São Paulo, Brazil. Electronic address: · Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua 3 de maio 100, Ed. INFAR, 3rd floor, CEP 04044-020 São Paulo, Brazil. Electronic address: · Pubmed 30321766
  • Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada. · Depression and Bipolar Support Alliance (DBSA), Chicago, IL, United States; Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States. · Depression and Bipolar Support Alliance (DBSA), Chicago, IL, United States. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada; Depression and Bipolar Support Alliance (DBSA), Chicago, IL, United States. Electronic address: · Pubmed 30241026
2018
  • Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA. · Department of Psychiatry, University of Minnesota, Minneapolis, MN, USA. · Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada. · Departments of Psychiatry and Obstetrics & Gynaecology, Western University, London, ON, Canada. · Department of Psychiatry, McGill University, Montreal, QC, Canada. · Department of Psychiatry, Dalhousie University, Halifax, NS, Canada. · Department of Psychiatry, University of Calgary, Calgary, AB, Canada. · Departments of Psychiatry and Psychology, Queen's University, Kingston, ON, Canada. · School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada. · Department of Neuropsychiatry, Kyushu University, Fukuoka, Japan. · Department of Psychiatry, University of Sao Paulo, Sao Paulo, Brazil. · Bipolar and Depression Research Program, VA Palo Alto, Department of Psychiatry & Behavioral Sciences Stanford University, Stanford, CA, USA. · Department of Psychiatry, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH, USA. · Bipolar Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain. · Department of Psychiatry, University of Sydney, Sydney, NSW, Australia. · Department of Psychiatry, George Washington University, Washington, DC, USA. · Deakin Univeristy, IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Geelong, Vic., Australia. · Pubmed 29536616
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada. · Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychological Medicine, National University of Singapore, Singapore. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Brain and Cognition Discovery Foundation, Toronto, ON, Canada Institute of Medical Science, University of Toronto, Toronto, ON, Canada Department of Psychiatry, University of Toronto, Toronto, ON, Canada Department of Pharmacology, University of Toronto, Toronto, ON, Canada. · Pubmed 30524702
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada; Department of Psychiatry, Federal University of São Paulo (Unifesp), São Paulo, Brazil. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. · Unitat Docent de Psiquiatria i Psicologia Mèdica, Departament de Medicina, Universitat de València, Valencia Unitat de Salut Mental de Catarroja, Valencia Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto Carlos III, Madrid International Society for Nutritional Psychiatry Research (ISNPR), Spain. · Psychiatric Centre Copenhagen, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. · Hospital Universitario de Alava-Santiago, CIBERSAM, EHU, Vitoria, Spain. · Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Department of Psychological Medicine, National University Health System, Singapore, Singapore. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada. · Pubmed 30075165
  • UHN-Toronto Western Hospital, Mood Disorders Psychopharmacology Unit, University of Toronto, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. · Department of Psychological Medicine, King's College London and South London and Maudsley NHS Foundation Trust, London, UK. · Neuroscience and Psychiatry Unit, University of Manchester, Manchester, UK. · Pubmed 29977518
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, Federal University of São Paulo, São Paulo 05403-903, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Department of Pharmacology, University of Toronto, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. · Pubmed 29673146
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Institute of Medical Science, University of Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. · Pubmed 29481915
  • Mood Disorder Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 29102836
  • Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil; Mood Disorders Psychpharmachology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), University of Toronto, Toronto, Canada. Electronic address: · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Mood Disorders Psychpharmachology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Pubmed 28830676
  • Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada. · Depression and Bipolar Support Alliance, Chicago, Illinois, USA. · Kaiser Permanente Washington Health Research Insitute, Seattle, Washington, USA. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, 399 Bathurst St, MP 9-325, Toronto, ON M5T 2S8, Canada. · Pubmed 30444959
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. Electronic address: · Department of Psychiatry and Behavioral Sciences, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, USA. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA. · Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; Centre for Neuroscience Studies, Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada. · Center for Neuroscience in Women's Health, Stanford University, Palo Alto, USA. · Laboratory of Neuroendocrinology, The Rockefeller University, New York, USA. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo, SP, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; University of Toronto, Toronto, Canada. · Pubmed 30391805
  • 1 School of Psychiatry - University of New South Wales and Black Dog Institute, Randwick, NSW, Australia. · 2 Department of Psychiatry, University of Calgary, Calgary, AB, Canada. · 3 IMPACT SRC, School of Medicine, Barwon Health, Deakin University, Geelong, VIC, Australia. · 4 Department of Psychiatry, Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health and the Florey Institute for Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia. · 5 Allgemeinpsychiatrie Ost, Klinikum am Weissenhof, Weinsberg, Germany. · 6 Paracelsus Medical Private University (PMU) Nuremberg, Nuremberg, Germany. · 7 Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · 8 Center for Anxiety & Depression, Mercer Island, WA, USA. · 9 Department of Psychiatry & Behavioral Sciences, University of Washington, Seattle, WA, USA. · 10 School of Medicine, Case Western Reserve University, Cleveland, OH, USA. · 11 Depression Research Unit, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · 12 Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. · 13 Department of Psychiatry, The University of British Columbia, Vancouver, BC, Canada. · 14 The Copenhagen Affective Disorder Research Center (CADIC), Psychiatric Center Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark. · 15 Division of Psychiatry, School of Medicine, The University of Western Australia, Perth, WA, Australia. · 16 Department of Psychiatry and Human Behavior, Brown University, and Rhode Island Hospital, Providence, RI, USA. · 17 3rd Department of Psychiatry, Division of Neurosciences, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. · 18 Department of Psychiatry, Queen's University, Kingston, ON, Canada. · 19 Department of Psychiatry, Dalhousie University, Halifax, NS, Canada. · 20 Departments of Psychiatry and Medical Neuroscience, Dalhousie University, Halifax, NS, Canada. · 21 Department of Psychiatry, Western University, London, ON, Canada. · 22 Center for Behavioral Health, Cleveland Clinic, Cleveland, OH, USA. · 23 Discipline of Psychiatry, Westmead Clinical School, Sydney Medical School, University of Sydney, Westmead, NSW, Australia. · 24 Mood Disorders Program, Department of Psychiatry and Behavioural Neurosciences, McMaster University and Women's Health Concerns Clinic, St. Joseph's Healthcare, Hamilton, ON, Canada. · 25 The University of Melbourne and St Vincent's Hospital, Melbourne, VIC, Australia. · 26 The Centre for Affective Disorders, King's College London, London, UK. · 27 Hospital Clinic of Barcelona, Clinic Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain. · 28 Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland. · 29 Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. · 30 Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · 31 Centre for Mental Health, Swinburne University of Technology, Melbourne, VIC, Australia. · 32 Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne, Carlton, VIC, Australia. · 33 Department of Psychiatry, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey. · 34 School of Medicine & Health Sciences, The George Washington University, Washington, DC, USA. · 35 Bipolar Collaborative Network, Bethesda, MD, USA. · 36 Department of Psychiatry, VA Palo Alto Health Care System, Palo Alto, CA, USA. · 37 Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. · 38 Department of Psychiatry, School of Medicine, University of São Paulo, São Paulo, Brazil. · 39 Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London, London, UK. · 40 Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · 41 AP-HP, Hôpitaux Universitaires Henri Mondor, DHU Pepsy, Pôle de Psychiatrie et d'Addictologie, Université Paris-Est Créteil Val de Marne, Créteil, France. · 42 Department of Neuropsychiatry, Kyushu University, Fukuoka, Japan. · 43 Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA. · 44 Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA. · 45 New York State Psychiatric Institute, Columbia University, New York, NY, USA. · 46 Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · 47 Open Sky Psychology, Ryde, NSW, Australia. · 48 Veterans Affairs Boston Healthcare System, Harvard Medical School, Boston, MA, USA. · 49 Department of Psychiatry and Psychology, Mayo Clinic College of Medicine, Rochester, MN, USA. · 50 Department of Psychiatry, University of Toronto and Brain and Cognition Discovery Foundation, Toronto, ON, Canada. · 51 Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy. · 52 Psychology Clinic, University of New South Wales, Sydney, NSW, Australia. · 53 Psychology Clinic, Black Dog Institute, Randwick, NSW, Australia. · 54 Department of Psychiatry and Behavioral Health, Stony Brook University School of Medicine, Stony Brook, NY, USA. · 55 CADE Clinic, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, NSW, Australia. · 56 Academic Department of Psychiatry, Northern Sydney Local Health District, St Leonards, NSW, Australia. · 57 Discipline of Psychiatry, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 30378461
  • Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil. · Laboratory of Emotion and Cognition, Department of Affective Disorders, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China; Department of Neuropsychology, University of Hong Kong, Hong Kong, China. · School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Psychiatry, Chang Gung Memorial Hospital, Chiayi, Taiwan. · Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. · Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30153635
  • Johns Hopkins University and the Kennedy Krieger Institute, Baltimore, MD, USA, · Allergan, Madison, NJ, USA. · VA Palo Alto Health Care System, Palo Alto, CA, USA. · Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. · Toronto Western Research Institute, Toronto, ON, Canada. · Pubmed 30122926
  • Case Management Unit, Institute of Mental Health, Singapore. · Department of General and Forensic Psychiatry, Institute of Mental Health, Singapore. · Research Division, Institute of Mental Health, Singapore. · Department of General Psychiatry, Institute of Mental Health, Singapore. · Department of Psychiatry and Psychology, Institute of Neuroscience, University of Barcelona, IDIBAPS0-CIBERSAM, Barcelona, Spain. · Departments of Psychiatry and Pharmacology and Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of General Psychiatry, Institute of Mental Health/Woodbridge Hospital 10, Buangkok View, Singapore 539747. · Pubmed 29727072
  • Medical University of Graz, Department of Psychiatry and Psychotherapeutic Medicine, Graz, Austria. · Medical University of Graz, Department of Psychiatry and Psychotherapeutic Medicine, Graz, Austria. Electronic address: · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Graz, Austria. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 29433074
  • Dent Neurologic Institute, Amherst, NY, USA. · University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, USA. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 29427512
  • Department of Psychiatry, Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital at Chiayi, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan. · School of Medicine, Chang Gung University, Taoyuan, Taiwan; Health Information and Epidemiology Laboratory, Chang Gung Memorial Hospital, Chiayi, Taiwan; Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University, College of Public Health, Taipei, Taiwan. · Health Information and Epidemiology Laboratory, Chang Gung Memorial Hospital, Chiayi, Taiwan. · University of California, San Francisco (UCSF), USA. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Canada; Department of Psychiatry, University of Toronto, Canada. · Department of Speech, Language Pathology and Audiology, Chung Shan Medical University, Taiwan. · Department of Medicine, Mackay Medical College, Taipei, Taiwan; Department of Psychiatry, Mackay Memorial Hospital, Taipei, Taiwan; Department of Audiology, Speech, and Language Pathology, Mackay Medical College, Taipei, Taiwan. Electronic address: · Pubmed 28972929
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28944976
  • Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada. · Grupo de Pesquisa em Neurociência Comportamental e Molecular do Transtorno Bipolar, Departamento de Psiquiatria, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Pubmed 30156658
2017
  • Department of Psychiatry, University of Toronto, Toronto, ON M5T 2S8, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 2S8, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada. · Pubmed 29084144
  • Department of Psychiatry, Texas Tech University Health Sciences Center Medical School, Midland, Texas, USA. · Department of Neuropsychiatry and Behavioral Sciences, University of South Carolina School of Medicine, Greer, South Carolina, USA. · Mood Disorders Psychopharmacology Unit, University of Toronto, Ontario, Canada. · Pubmed 28994900
  • a Department of Psychiatry , University of Toronto , Toronto , Canada. · b Mood Disorders Psychopharmacology Unit , University Health Network , Toronto , Canada. · c Brain and Cognition Discovery Foundation , Toronto , Canada. · d Neuralstem , 20271 Goldenrod Lane, Germantown , MD 20876 , USA. · Pubmed 28460574
  • University of São Paulo (USP), São Paulo, Brazil; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. Electronic address: · Pubmed 28107669
  • Mood Disorder Psychopharmacology Unit,University Health Network,Department of Psychiatry,University of Toronto,Toronto,Ontario,Canada. · Pubmed 27618746
  • VA Palo Alto Health Care System and Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA. · H. Lundbeck A/S, Valby, Copenhagen, Denmark. · Department of Clinical Sciences, Lund University, Lund, Sweden. · Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London, London, UK. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, ON, Canada. · Pubmed 29105003
  • Department of Psychiatry, Psychiatric Center Copenhagen, Copenhagen, Denmark. · Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. · Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark. · Department of Biostatistics, University of Copenhagen, Copenhagen, Denmark. · Department of Applied Mathematics and Computer Science, Technical University of Denmark, Kongens Lyngby, Denmark. · Gene Regulation Bioinformatics at the Bioinformatics Centre, Department of Biology/BRIC, University of Copenhagen, Copenhagen, Denmark. · The Centre of Inflammation and Metabolism at Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark. · Laboratory of Clinical Pharmacology, Rigshospitalet, Copenhagen, Denmark. · Department of Psychiatry and Pharmacology, University of Toronto, Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada. · McMaster University, Hamilton, Ontario, Canada. · Department and Institute of Psychiatry, and Laboratory of Neuroscience (LIM27), University of São Paulo Medical School, São Paulo, Brazil. · IT University Copenhagen, Copenhagen, Denmark. · Create-Net: Center for Research and Telecommunications Experimentation for Networked Communities, Trento, Italy. · Neurobiology Research Unit and Center for Integrated Molecular Brain Imaging, Rigshospitalet, Copenhagen, Denmark. · Department of Psychiatry, University of Pittsburgh, Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, USA. · Pubmed 28645967
  • Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, Kuwait University, Kuwait City, Kuwait. · Psychosocial Oncology Clinic, University Health Network, Toronto, ON, Canada. · Department of Psychology, University of Toronto, Toronto, ON, Canada. · Neuropsychology Clinic, University Health Network, Toronto, ON, Canada. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Department of Psychiatry, Women's College Hospital, Toronto, ON, Canada. · Department of Toxicology and Pharmacology, University of Toronto, Toronto, ON, Canada. · Pubmed 28599348
  • Department of Affective Disorders, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology, University of Toronto, Ontario, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Laboratory of Emotion and Cognition, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong. · Pubmed 28493605
  • Department of Psychiatry and Psychotherapy, Medical University of Graz, Graz, Austria. · Department of Psychiatry and Psychotherapy, Medical University of Graz, Graz, Austria. Electronic address: · Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria. · Division of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria. · Institute of Laboratory Medicine, Medical Center of Munich University (LMU), Munich, Germany. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 28482311
  • Department of Psychiatry, Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital at Chiayi, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Nursing, Chang Gung Institute of Technology, Taoyuan, Taiwan. · Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital at Chiayi, Taiwan. · School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Neurosurgery, Chang Gung Memorial Hospital at Chiayi, Taiwan. · Center of Excellence for Chang Gung Research Datalink, Chang Gung Memorial Hospital at Chiayi, Taiwan. · Center of Excellence for Chang Gung Research Datalink, Chang Gung Memorial Hospital at Chiayi, Taiwan; Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital, at Chiayi, Taiwan; Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University College of Public Health, Taipei, Taiwan. · Department of Psychiatry, Wan-Fang Hospital & School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. · Department of Neurology, Kaohsiung Medical University and Hospital, Kaohsiung, Taiwan. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Department of Psychiatry, Chung Shan Medical University Hospital, Taichung, Taiwan; Department of Psychiatry, School of Medicine, Chung Shan Medical University, Taichung, Taiwan. · Department of Psychiatry, Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital at Chiayi, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan. Electronic address: · Pubmed 28477503
  • Reserach Group in Behavioral and Molecular Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 28457001
  • University of Toronto, MDPU-BCDF, Toronto, Canada. · Sunovion Pharmaceuticals Inc., Marlborough, MA, USA. Electronic address: · Vertex Pharmaceuticals Inc., Boston, MA, USA. · Optum, Prairie, MN, USA. · Kantar Health, New York, NY, USA. · Sunovion Pharmaceuticals Inc., Marlborough, MA, USA. · Sunovion Pharmaceuticals Inc., Fort Lee, NY, USA. · Pubmed 28073041
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Division of Endocrinology, Mount Sinai Hospital, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Research Division, Institute of Mental Health, Singapore. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Department of Psychiatry, Stanford University, Palo Alto, CA, United States. · Department of Psychiatry, Dalhousie University, Halifax, Canada. · Pubmed 27721184
  • Mood Disorder Psychopharmacology Unit,University Health Network,Department of Psychiatry,University of Toronto,Toronto,Ontario,Canada. · Pubmed 27629159
2016
  • Departments of Psychiatry and Pharmacology, Mood Disorders Psychopharmacology Unit, University of Toronto, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada. · Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceará, Rua Prof. Costa Mendes, 1608, 4o andar, 60.430-140 Fortaleza, CE, Brazil. · Pubmed 26812953
  • Resident of Psychiatry, Clinician Scientist Stream, University of Toronto, Toronto, ON, Canada. · Resident of Psychiatry, Western University, London, ON, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Canada; Psychiatry and Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 27400335
  • Mood Disorders Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada. · Department of Psychiatry, Western University, London and Windsor, ON, Canada. · IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Vic., Australia. · Department of Psychiatry, The Florey Institute of Neuroscience and Mental Health, and Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, University of Melbourne, Parkville, Vic., Australia. · Psychiatric Center Copenhagen, Faculty of Health and Medical Sciences and Department O, University of Copenhagen, Copenhagen, Denmark. · Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, São Paulo, Brazil. · Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Departments of Psychiatry, Pharmacology, and Psychological Clinical Science, Centre for Youth Bipolar Disorder, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. · Pubmed 26990051
  • Mood Disorder Psychopharmacology Unit, University Health Network, University of Toronto, 399 Bathurst Street, MP 9-325, Toronto, Ontario M5T 2S8, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, University of Toronto, 399 Bathurst Street, MP 9-325, Toronto, Ontario M5T 2S8, Canada. Electronic address: · Pubmed 26876323
  • Research Division, Institute of Mental Health, Singapore, 10 Buangkok View, Singapore 539747, Singapore. · Department of General Psychiatry, Institute of Mental Health/Woodbridge Hospital, Singapore, 10 Buangkok View, Singapore 539747, Singapore. · Division of Psychiatry, Department of Molecular Medicine, University at Siena, Italy, Viale Bracci 1, 53100 Siena, Italy. · Mood Disorders Psychopharmacology Unit, University of Toronto, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON M5T 2S8, Canada. · Bipolar Disorders Program, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain. · Research Division, Institute of Mental Health, Singapore, 10 Buangkok View, Singapore 539747, Singapore; Department of General Psychiatry, Institute of Mental Health/Woodbridge Hospital, Singapore, 10 Buangkok View, Singapore 539747, Singapore. Electronic address: · Pubmed 26691725
  • Merck, Whitehouse Station, NJ, USA. · Forest Research Institute (now Actavis), Jersey City, NJ, USA. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, ON, Canada. · Forest Research Institute (now Actavis), Jersey City, NJ, USA. Electronic address: · Pubmed 26496015
  • Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 27488494
  • Faculty of Kinesiology and Physical Education, University of Toronto, 55 Harbord Street, Toronto, ON, M5S2W6, Canada. · School of Kinesiology, University of British Columbia, 2146 Health Sciences Mall, Room 4606, Vancouver, BC, V6T 1Z3, Canada. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, 399 Bathurst Street, MP 9-325, Toronto, ON, M5T 2S8, Canada. · Schizophrenia Program Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada. · School of Kinesiology, University of British Columbia, 2146 Health Sciences Mall, Room 4606, Vancouver, BC, V6T 1Z3, Canada. · Pubmed 27405745
  • Department of Psychiatry, Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Bipolar Disorder Program and Laboratory of Molecular Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · Pubmed 27324989
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 27281261
  • Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Centre for Research in Occupational Safety and Health, Laurentian University, Sudbury, Ontario, Canada. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; University Health Network in Toronto, Ontario, Canada. · University of Calgary in Calgary, Alberta, Canada. · Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · University of British Columbia, Vancouver, British Columbia, Canada. · Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 27182964
  • Department of Psychiatry, Medical University of Graz, Graz, Austria. · Department of Psychology, Karl-Franzens University of Graz, Graz, Austria. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria. · Division of Biological Chemistry, Innsbruck Medical University, Innsbruck, Austria. · Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich, Germany. · Pubmed 27016286
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26866976
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26748249
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Cleveland Clinic, Cleveland, OH, USA. · Turn2Health Solutions, Willoughby, OH, USA. · Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil. · Department of Neuropsychiatry, University of South Carolina School of Medicine, USA. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26508286
2015
  • Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26363613
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 25579847
  • (a)Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil. Electronic address: · Department of Public Health, Epidemiology and Biostatistics, University of Birmingham, Birmingham, UK. · (a)Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil. · Mood Disorders Psychopharmacology Unit, University of Toronto, Toronto, ON, Canada. · Memory Research Laboratory, Brain Institute (ICe), Federal University of Rio Grande do Norte (UFRN), Natal, RN, Brazil. · Laboratory of Neurosciences, Graduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, Criciúma, SC, Brazil; Center for Experimental Models in Psychiatry, Department of Psychiatry and Behavioral Sciences, The University of Texas Medical School at Houston, Houston, TX, USA. · Department of Psychiatry, University of Ioaninna, Ioaninna, Greece. · Mood Disorders Psychopharmacology Unit, University of Toronto, Toronto, ON, Canada; Departments of Psychiatry and Pharmacology, University of Toronto, Toronto, ON, Canada. · Bipolar Disorders Unit, Clinical Institute of Neurosciences, Hospital Clinic, IDIBAPS, University of Barcelona, CIBERSAM, Barcelona, Catalonia, Spain. · Pubmed 25451435
  • Department of Psychiatry, Medical University of Graz, Graz, Austria. · Department of Neurology, Medical University of Graz, Graz, Austria. · Department of Neurology, Medical University of Graz, Graz, Austria; Division of Neuroradiology, Department of Radiology, Medical University of Graz, Graz, Austria. · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Graz, Austria. · Division of Neuroradiology, Department of Radiology, Medical University of Graz, Graz, Austria. · Mood Disorders Psychopharmacology Unit at the University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26252714
  • Professor of Psychiatry and Pharmacology, Head, Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, Ontario, Canada. · Pubmed 26172636
  • Psychiatric Center Copenhagen, Department O and University of Copenhagen Denmark. Electronic address: · Department of Biostatistics University of Copenhagen Copenhagen, Denmark. · Department of Psychiatry and Pharmacology University of Toronto, Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ont., Canada. · Pubmed 25909752
  • University of Toronto, Departments of Psychiatry and Pharmacology, Mood Disorders Psychopharmacology Unit, 399 Bathurst St, MP 9-325, Toronto, ON, Canada M5T 2S8 · Pubmed 25844756
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Cleveland Clinic, Cleveland, OH, USA. · Medco Health Solutions, Inc, Fort Worth, TX, USA. · Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 25451425
  • Department of Psychiatry, Medical University of Graz, Graz, Austria. · Institute of Pathophysiology and Immunology, Medical University of Graz, Austria. · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Auenbruggerplatz 15, 8043 Graz, Austria. · Research Unit on Lifestyle and Inflammation-associated Risk Biomarkers, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Auenbruggerplatz 15, 8043 Graz, Austria; BioTechMed-Graz, Austria. Electronic address: · Division of Biological Chemistry, Innsbruck Medical University, Innsbruck, Austria. · Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada; Department of Psychiatry and Pharmacology at the University of Toronto, Toronto, Canada. · Pubmed 25443762
2014
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 25090934
  • Department of Clinical Medicine and Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil. Electronic address: · Department of Psychiatry and Mood Disorders Psychopharmacology Unit, University of Toronto, Toronto, ON, Canada. · 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. · Department of Clinical and Theoretical Mental Health, Kutvolgyi Clinical Center, Semmelweis University, Budapest, Hungary; Department of Pharmacodynamics, Semmelweis University, Budapest, Hungary; Neuropsychopharmacology and Neurochemistry Research Group, National Academy of Sciences and Semmelweis University, Budapest, Hungary; National Institute of Psychiatry and Addictions, Laboratory for Suicide Research and Prevention, Budapest, Hungary. · IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, VIC, Australia; Department of Psychiatry, The Florey Institute of Neuroscience and Mental Health, and Orygen Youth Health Research Centre, University of Melbourne, Parkville, VIC, Australia. · Department of Clinical Medicine and Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil. · Department of Psychiatry, University of Ioaninna, Ioaninna, Greece. · Department of Psychiatry, Psychotherapy and Psychosomatics, Zurich University Hospital, Zurich, Switzerland. · Pubmed 24836088
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Department of Morphology and Genetics, Federal University of São Paulo, São Paulo, Brazil. · Institute of Biomedical Research and Faculty of Biosciences, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Pubmed 24548785
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Schulich School of Medicine and Dentistry, Western University, London, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 24468642
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 24330342
  • University of New Mexico, Health Sciences Center, Department of Psychiatry, Albuquerque, NM, USA. · University of Toronto, Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Kyushu University, Department of Neuropsychiatry, Fukuoka, Japan; East Asian Bipolar Forum, Fukuoka, Japan. · Eli Lilly Japan K.K., Lilly Research Laboratories, Statistical Science, Kobe, Japan. · Eli Lilly Japan K.K., Lilly Research Laboratories, Medical Science, Sannomiya Plaza Building, 7-1-5, Isogamidori, Chuo-ku, Kobe 651-0086, Japan. Electronic address: · Pubmed 25046739
  • University of New Mexico, Health Sciences Center, Department of Psychiatry, Albuquerque, NM, USA. · Kyushu University, Department of Neuropsychiatry, Fukuoka, Japan; East Asian Bipolar Forum, Fukuoka, Japan. · University of Toronto, Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Eli Lilly Japan K. K., Lilly Research Laboratories, Statistical Science, Kobe, Japan. · Eli Lilly Japan K. K., Lilly Research Laboratories, Medical Science, Kobe, Japan. Electronic address: · Pubmed 24856554
  • Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil; Department of Clinical Medicine, Faculty of Medicine, Fortaleza, Ceará, Brazil. Electronic address: · Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil. · Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil; Department of Clinical Medicine, Faculty of Medicine, Fortaleza, Ceará, Brazil. · Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil; Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, Ceará, Brazil. · 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. · Mood Disorders Unit (GRUDA), Department and Institute of Psychiatry, School of Medicine, University of Sao Paulo (IPq-HC-FMUSP), Brazil. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, School of Medicine, University of Ioannina, Ioannina, Greece. · Pubmed 24767016
2013
  • 1 Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · 3 Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Pubmed 24237641
  • Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada; Department of Psychiatry, University Health Network, Toronto, Canada. · Pubmed 24014142
2012
  • Mood Disorders Psychopharmacology Unit, University Health Network, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Pubmed 22563572
  • Mood Disorders Psychopharmacology Unit, University Health Network, Departments of Psychiatry and Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 22303523
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 22510034
  • Department of Psychiatry, University of Toronto, Toronto, Canada. · Pubmed 22182459
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 23107220
  • University of Toronto, Canada University Health Network, Canada. · Pubmed 22849038
2011
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 20950326
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; · Pubmed 21655345
  • Department of Psychiatry, University of Toronto, and Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Pubmed 21450149
  • Department of Psychiatry, University of Toronto, Ontario, Canada. · Pubmed 21382301
2010
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 20541810
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Pubmed 20420486
  • Department of Psychiatry, University of Toronto, Canada. · Pubmed 20152551
  • Department of Psychiatry, University of Toronto, ON, Canada. · Pubmed 20878373
  • Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, ON, Canada. · Pubmed 20537396
  • University of Toronto, Toronto, ON, Canada M5T 2S8. · Pubmed 20096936
2018
  • University of Toronto, Toronto, Canada. · Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada. · Depression and Bipolar Support Alliance (DBSA), Chicago, Illinois. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Guangzhou Medical University, Guangzhou, China. · College of Medicine, Korea University, Seoul, Republic of Korea. · Pubmed 30412345
2016
  • aDepartment of Psychiatry, Dalhousie University, Halifax, CanadabNational Institute of Mental Health, Klecany, Czech RepubliccDepartment of Psychiatry, University of Toronto, Toronto, Canada. · Pubmed 26575297
2014
  • Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil (Dr Carvalho); Center for Experimental Models in Psychiatry, Department of Psychiatry and Behavioral Sciences, The University of Texas Medical School at Houston, Houston, TX (Dr Quevedo); Laboratory of Neurosciences, Graduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, Criciúma, SC, Brazil (Dr Quevedo); Departments of Psychiatry and Pharmacology and Mood Disorders Psychopharmacology Unit, University of Toronto, Toronto, ON, Canada (Dr McIntyre); Mood Disorders Unit (GRUDA), Department and Institute of Psychiatry, School of Medicine, University of São Paulo (IPq-FMUSP), São Paulo, Brazil (Dr Souza); 3rd Department of Psychiatry, Aristotle University of Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Victoria, Australia (Dr Berk); Department of Psychiatry, the Florey Institute of Neuroscience and Mental Health, and Orygen Youth Health Research Centre, University of Melbourne, Parkville, Australia (Dr Berk); Department of Psychiatry, Medical School, University of Ioaninna, Ioaninna, Greece (Dr Hyphantis); Bipolar Disorders Unit, Clinical Institute of Neurosciences, Hospital Clinic, IDIBAPS, University of Barcelona, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta) · Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil (Dr Carvalho); Center for Experimental Models in Psychiatry, Department of Psychiatry and Behavioral Sciences, The University of Texas Medical School at Houston, Houston, TX (Dr Quevedo); Laboratory of Neurosciences, Graduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, Criciúma, SC, Brazil (Dr Quevedo); Departments of Psychiatry and Pharmacology and Mood Disorders Psychopharmacology Unit, University of Toronto, Toronto, ON, Canada (Dr McIntyre); Mood Disorders Unit (GRUDA), Department and Institute of Psychiatry, School of Medicine, University of São Paulo (IPq-FMUSP), São Paulo, Brazil (Dr Souza); 3rd Department of Psychiatry, Aristotle University of Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Victoria, Australia (Dr Berk); Department of Psychiatry, the Florey Institute of Neuroscience and Mental Health, and Orygen Youth Health Research Centre, University of Melbourne, Parkville, Australia (Dr Berk); Department of Psychiatry, Medical School, University of Ioaninna, Ioaninna, Greece (Dr Hyphantis); Bipolar Disorders Unit, Clinical Institute of Neurosciences, Hospital Clinic, IDIBAPS, University of Barcelona, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta). · Pubmed 25522415
2013
  • Department of Human Biology, University of Toronto, Toronto, ON, Canada. · Pubmed 24194362
2012
  • Mood and Anxiety Disorders Program, Sunnybrook Health Sciences Centre, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Pubmed 22303519
2010
  • Division of Neurosurgery, University Health Network Department of Psychiatry, University of Toronto, University Health Network, 399 Bathurst Street, Toronto, Ontario, Canada. · Pubmed 21040286
  • University of Toronto, Ontario, Canada. · Pubmed 20840804
Miscellaneous institutions in Toronto
2019
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Department of Psychiatry, University of Toronto, Toronto, Canada. · Department of Psychiatry, Queen's University, Kingston, Canada. · Department of Psychiatry, Research Group in Molecular and Behavioral Neurosciences of Mood Disorders, Universidade Federal de São Paulo, Sao Paulo, Brazil. · Brain and Cognition Discovery Foundation, Toronto, Canada. · Pubmed 31464359
  • a Department of Psychiatry and Pharmacology , University of Toronto , Toronto , Canada. · b Mood Disorders Psychopharmacology Unit, University Health Network , Toronto , Canada. · c Brain and Cognition Discovery Foundation , Toronto , Canada. · d Department of Psychiatry and Gastroenterology, McMaster University , Hamilton , Canada. · Pubmed 31132957
2018
  • Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada. · Grupo de Pesquisa em Neurociência Comportamental e Molecular do Transtorno Bipolar, Departamento de Psiquiatria, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Brain and Cognition Discovery Foundation (BCDF), Toronto, ON, Canada. · Pubmed 30156658
2017
  • a Department of Psychiatry , University of Toronto , Toronto , Canada. · b Mood Disorders Psychopharmacology Unit , University Health Network , Toronto , Canada. · c Brain and Cognition Discovery Foundation , Toronto , Canada. · d Neuralstem , 20271 Goldenrod Lane, Germantown , MD 20876 , USA. · Pubmed 28460574
  • Institute of Biosciences University of São Paulo (USP). R. do Matão, 14, 321 - Butantã, São Paulo, SP, 05508-090, Brazil,; Research Group of Behavioral and Molecular Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo (Unifesp). R. Pedro de Toledo, 669-3rd Floor, Vila Clementino, São Paulo, SP, CEP 04039-032, Brazil. Electronic address: · Research Group of Behavioral and Molecular Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo (Unifesp). R. Pedro de Toledo, 669-3rd Floor, Vila Clementino, São Paulo, SP, CEP 04039-032, Brazil; Mood Disorders Psychopharmachology Unit (MDPU), University of Toronto. 399 Bathurst Street, MP 9-325, Toronto, Ontario, M5T 2S8, Canada. · Research Group of Behavioral and Molecular Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo (Unifesp). R. Pedro de Toledo, 669-3rd Floor, Vila Clementino, São Paulo, SP, CEP 04039-032, Brazil. · Department of Physiological Science, Santa Casa de São Paulo Medical School. R. Doutor Cesário Motta Júnior, 61 - Vila Buarque, São Paulo - SP, 01221-020 Brazil. · Mood Disorders Psychopharmachology Unit (MDPU), University of Toronto. 399 Bathurst Street, MP 9-325, Toronto, Ontario, M5T 2S8, Canada. · Pubmed 27871787
2018
  • University of Toronto, Toronto, Canada. · Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada. · Depression and Bipolar Support Alliance (DBSA), Chicago, Illinois. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Guangzhou Medical University, Guangzhou, China. · College of Medicine, Korea University, Seoul, Republic of Korea. · Pubmed 30412345
2012
  • Toronto East General Hospital Day, Treatment Program, East York, Ontario, Canada. · Pubmed 22303522
Miscellaneous institutions in Chicago
2018
  • Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada. · Depression and Bipolar Support Alliance, Chicago, Illinois, USA. · Kaiser Permanente Washington Health Research Insitute, Seattle, Washington, USA. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, 399 Bathurst St, MP 9-325, Toronto, ON M5T 2S8, Canada. · Pubmed 30444959
2018
  • University of Toronto, Toronto, Canada. · Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada. · Depression and Bipolar Support Alliance (DBSA), Chicago, Illinois. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Guangzhou Medical University, Guangzhou, China. · College of Medicine, Korea University, Seoul, Republic of Korea. · Pubmed 30412345
Unspecified
26 Other Locations Show
Yearly article counts 12123201812121417811
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.